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ABSTRACT 
Remodelling the Cavity of a Transmembrane Pore  
by Genetic Engineering. (May 2005) 
Yun Hee Jung, B.S., Seoul National University; 
M.S., Seoul National University 
Co-Chairs of Advisory Committee: Dr. Hagan Bayley  
               Dr. Nick Pace 
The cavity within the transmembrane staphylococcal α-hemolysin (αHL) pore is 
roughly a sphere of diameter ~45 Å (volume ~32,600 Å3). The alpha-hemolysin gene 
was modified to introduce exogenous polypeptide sequences between positions 105 and 
106 of αHL. These modified αHLs were assembled either by themselves or with wild-
type (W) subunits to form stable homoheptamers and heteroheptamers, respectively. 
First, the ability to accommodate Gly/Ser-rich polypeptide sequences in the central 
cavity was tested. Concatemerized Gly/Ser-containing sequences ("loops", L; L(10n + 
5), n = 0 to 21) were inserted by genetic approaches. Detailed analysis of bilayer 
recordings and electrophoretic migration patterns of assembled pores indicate that the 
upper capacity of the cavity is ~175 amino acids. Then two different polypeptides were 
placed in the cavity to introduce novel functional properties to the αHL pore. By 
introducing tandem repeats of elastin-like polypeptide sequences (VPGGG), αHL pores 
(E101W6) that featured a temperature-responsive gating mechanism were obtained. The 
temperature-dependent properties of E101W6 pores were monitored by single-channel 
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current recording in planar lipid bilayers. The amplitude and the frequency of the 
transient blockades increased as the temperature increased, while their duration 
decreased. The hydrophobic collapse of the inserted ELP loop is proposed for the source 
of the observed sigmoidal two-state transition for normalized closed states of E101W6 
pores. Lastly, an αHL pore was designed to detect proteins from the cis side of the 
membrane. The heat-stable protein kinase inhibitor (PKI) sequence was inserted into the 
mid-position of the Gly/Ser loop, which was generated by previous project (L105 
construct). The heteromeric pore with the PKI-containing loop (P1151W6) was able to 
detect cAMP-dependent protein kinase catalytic subunit (PKA) at single molecular level. 
These engineered αHL pores provide numerous possibilities as tools for drug delivery, 
cryopreservation, or molecular sensing. 
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CHAPTER I 
INTRODUCTION 
 
The α-hemolysin (αHL) pore is an exotoxin secreted by Staphylococcus aureus. 
It is secreted as a water soluble monomeric form and assembles into a mushroom-shaped 
pore with known three-dimensional structure (1) on susceptible cell membranes (2). The 
pore has been useful for fundamental studies of membrane protein assembly and 
function. Furthermore, it can be applied in biotechnology to prepare sensors (3) or to 
make for tools to permeabilize cells for the introduction of cryoprotectants (4). The pore 
has also been used as a nanoreactor to observe covalent chemistry at the single molecule 
level (5). 
αHL is a robust pore, e.g. it is stable up to 65ºC in the presence of SDS (6). This 
characteristic simplifies purification procedures for assembled αHL pore for single 
channel recordings. The structure of the heptameric pore is known in detail and the 
monomeric structure can be predicted from the structures of leukocidins, which are in 
the same class of β-barrel pore forming toxins (7-10). Furthermore, single channel 
electrical recordings are capable of analysing events on the microsecond time-scales, 
even with a minute amount of the protein. These features suggested αHL as the best  
_______________ 
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candidate for the present study, which involves redesigning a membrane pore. 
 
 
Figure 1. Structure of alpha-hemolysin and dimension of heptameric pore. 
Left. αHL protomer from the fully assembled pore consists of three domains, cap, rim and stem domains. 
The cap and rim domains reside on the extracellular surface of the membrane. The stem domain is 
composed of a 14-strand antiparallel β-barrel and defines the transmembrane domain of the pore. Right. A 
transverse section through the heptameric pore (7AHL) in a lipid bilayer. The widest region of the central 
cavity is ~45 Å in diameter while the narrowest region, ‘the constriction’, is only 14 Å in diameter. One of 
the seven Ser residues at position 106, where all the insertional mutations were generated for this study, is 
shown in red.  
 
 
 
 
Alpha-Hemolysin (αHL) 
Structures of αHL: fully assembled heptameric pore and water-soluble monomer 
The structure of the heptameric, active form of alpha-hemolysin (αHL) has been 
determined in the presence of detergent micelles (1, 11) at ~1.6 Å resolution. αHL is 
secreted as a monomeric water-soluble protein and assembles into a mushroom shaped 
heptameric pore on susceptible membranes (2, 12). The alpha-hemolysin pore comprises 
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cap, rim and stem domains (Figure 1) (1).  The cap domain consists of β sandwiches and 
amino latches, one of each contributed by each protomer. The rim domain (three β 
strands per protomer) lies just beneath the cap domain and in direct and/or indirect 
contact with the outer leaflet of the membrane bilayer. The cap and rim domains reside 
at the extracellular surface of the membrane. The stem domain is composed of a 14-
strand antiparallel β-barrel and defines the transmembrane domain of the pore. A water-
filled channel runs through the pore with non-cylindrical shape along the axis of 
molecular symmetry (11). The diameter of the channel ranges from 45 Å for the widest 
region in the cap to 14 Å for the narrowest region, known as the constriction (Figure 1). 
The opening of the pore at the cis side of the bilayer measures 30 Å in diameter and on 
the trans side 20 Å. 
 
Figure 2. Assembly process model of αHL pore.  
Assembly from a secreted soluble monomer to membrane-bound hemtameric pore. αHLs assemble from a 
soluble monomer (I) to form a putative membrane bound monomer state (II). This is followed by the 
formation of a prepore (III), which is finally transformed into the fully assembled pore (IV). The stem 
domain (residues 110-150) and the N-terminus (pink) are illustrated in pink where major conformation 
changes occur during assembly. The structures of water soluble-monomeric state is modeled with 
leukocidin monomer structure (1PVL). The heptameric pore structure (7AHL) was generated by SPOCK . 
This model was adapted from the work by Montoya M and Gouaux E.(2). 
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Assembly process 
Several studies support the idea that the mechanism of αHL assembly is in four 
stages (Figure 2) (2, 13-15). There is no structural information for the water-soluble 
monomeric form of αHL. But taking into account the fact that the core (i.e. excepting 
amino-latch region and pre-stem domain) of the water-soluble monomeric form of both 
leukocidin F (LukF) and leukocidin S (LukS) subunit are very similar to the αHL 
protomers (9, 16, 17), the structures of these monomers (Figure 3) are generally 
presumed to resemble the monomeric structure of αHL, even though the sequence 
identity is only ~20-30%(18) between the αHL and the leukocidin monomers (9). αHLs 
are secreted as water-soluble monomers (I). Upon binding to a susceptible membrane 
bilayer, membrane-bound monomers (II) associate to form the pre-pore (III). The pre-
stem region of the pre-pore then extends through the bilayer to generate the SDS-stable 
heptameric pore. The amino-latch and pre-stem region are sensitive to proteolysis, at 
Lys-8 and Lys-31, respectively.  During the assembly pathway, the pre-stem region in 
the pre-pore state (III) shows resistance to proteolysis, indicating encapsulation of the 
pre-stem region inside cap domain. However, the amino-latch remains sensitive in the 
pre-pore state (III) (15, 19). The pre-pores can be dissociated to monomers by sodium 
dodecyl sulfate (SDS), even at room temperature (13). In contrast, fully assembled 
heptameric pores are stable in SDS even at elevated temperature (~ 65ºC) (13). In the 
heptameric state, both the amino-latch and stem regions are resistant to proteolysis (13). 
Biophysical studies with covalently attached fluorescent probes (12, 13) and 
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biochemical studies on site-directed cysteine αHL mutants (20, 21) also confirmed this 
assembly mechanism model. 
 
 
Figure 3. The structures of a αHL protomer and leukocidin monomers. 
The Panton-Valentine leukocidin monomers, LukF-PV (1PVL) and LukS-PV (1T5R), from 
Staphylococcus aureus share very similar structure with an αHL protomer removed from the structure of 
the fully assembled αHL heptamer. The amino latch and the stem (prestem for the leukocidin monomers) 
domains are illustrated in violet.  
 
Protein engineering of αHL and applications in biotechnology 
 αHL has been used for a variety of applications in the biotechnology. Placement 
of a pentahistidine sequence at stem region (130-134) of αHL created a gating 
mechanism, controlled by the presence of divalent metal ions (22). αHL-H5 mutant (15), 
together with H35C mutant (6), were further studied to elucidated the assembly process. 
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αHL-H5 mutant was arrested at the prepore state when Zn(II) ions were presented. The 
prepore was proved to be a heptamer. This was the first time that an intermediate state in 
an assembly process had been achieved by the simple introduction of a metal binding 
motif  (pentahistidine) into the stem domain. Related metal-binding αHL mutants were 
developed for stochastic sensing of divalent metal ions (23). Various divalent metal ions 
bind reversibly to four engineered histidine residues near the turn of trans opening 
(residues 123, 125, 133 and 135) producing characteristic electrical traces. This behavior 
allowed the sensing of different concentrations of the metal ions simultaneously.  αHL 
has also developed as a sensor for organic molecules. One or two cyclodextrin lodged in 
the β-barrel can detect a variety of guest molecules, (24, 25) at single molecular level. In 
another case, the simple introduction of seven or fourteen arginine residues near the 
constriction region, allowed αHL to be used to detect the important cellular second 
messenger inositol 1,4,5-trisphosphate with nanomolar affinity (26). 
 Most of these modifications were placed at or near the β-barrel region. Recently, 
cysteine residues were placed near the cis-opening of the pore for the attachment of 
single strand DNA. The resulting DNA-αHL pore can sense duplex formation between 
the tethered DNA and the complementary DNA strand by changes of ionic current flow 
(27). In another approach, Gal-β-1,3-GalNAc was attached at the cis-mouth of the pore  
at position 9, to detect a lectin protein (28). Through single channel current recordings, 
divalent binding events could be distinguished from monovalent binding. 
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 Other positions engineered for the detection of molecules are the cap domain of 
the αHL pore, which is directly related to the present work. A single flexible biopolymer 
chain, polyethylene glycol 5.0 kDa (PEG 5K) was tethered at the Ser106Cys position  
through a disulfide bond (8). Interestingly, heptamers with two or more PEG chains did 
not form.  
 Besides chemical modification or point mutation, more drastic genetic 
engineering has also been performed on the αHL protein. The residues (25 residues) of 
the stem domain have been reversed by cassette mutagenesis (29). The pore with the 
reversed transmembrane domain (retro-αHL) exhibited a slightly reduced conductance 
and a symmetrical behavior with current-voltage relationships. The slightly assymetrical 
current-voltage relationship is one of the characteristics of the αHL pore. In other words, 
the αHL pore exhibits slightly high current amplitude at postive voltage than at negative 
voltage. Furthermore, when entire 25 amino-acid stem residues were removed, the 
mutant αHL (TCM) would still assemble into heptamers as confirmed by atomic force 
microscopy (14). The retro-αHL and TCM mutants suggested an extraordinary plasticity 
of alpha-hemolysin which might be very useful for the redesign of the αHL pores.  
 Other non-covalent modifications of the pore were designed as tools for single 
molecule DNA sequencing (30). Furthermore, the αHL pore has also been used as a 
nanoreactor to observe covalent chemistry at the single molecule level for the first time 
(5). 
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Figure 4. Elastin phase transition with temperature. 
ELP is known to undergo phase transition with temperature. At higher than transition temperature, ELP 
changes into dense structure, due to hydrophobic collapse. At below transition temperature, ELP changes 
into bulky ball by swelling. 
 
Elastin-like Polypeptide (ELP) Repeats 
The protein elastin is well known for its elasticity and resilience, which is used in 
many tissues. Native elastin motif VPGVG repeats more than eleven times in the native 
elastin polypeptides (31). Based on the native elastin pentapeptide, many designed 
elastin-like polypeptides (ELPs) have been made, which are composed of tandem repeats 
of the pentapeptide motif Val-Pro-Gly-X-Gly (where the ‘guest’ residue can be any 
amino acid except Pro) (32, 33). ELPs are known to undergo inverse temperature 
transitions, that they aggregate above a transition temperature (Tt) but remain in solution 
at below Tt (Figure 4) (34, 35). Tt is defined as the temperature at which the half-
maximal turbidity is observed. A proposed model for the inverse transition is based on a 
hydrophobic collapse which bound water  is shed (33, 36, 37). 
The inverse transition temperature can vary with intrinsic and extrinsic 
parameters (32). Intrinsic factors can be the identity of the guest residue, or the length of 
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the polymer chain. If alanine is introduced instead of valine as guest residue, Tt becomes 
higher than that recorded for native repeats with same length (38, 39). For polar amino 
acids (e.g. asparate) as the guest residues, a drastic increase of Tt (~45ºC) was observed 
(38, 40). The same increase in Tt was observed with longer polymers with same guest 
residue (33, 41).  Extrinsic factors are salt concentration, pH, or pressure (38, 42, 43). 
By adding sodium chloride to solution, it lowered the Tt value by 14ºC per 1N of NaCl. 
If the guest residue is an ionizable amino acid, such as Asp, Glu, or Lys, the pH of 
solution can change Tt. Lowering the pH to protonate a carboxyl side chain favors 
hydrophobic collapse of the polymer even at lower temperature.  Based on these 
fascinating characteristics of elastin-based polymers, numerous applications of ELP in 
biotechnology and medicine have been proposed (44-47).  
 
Cyclic AMP-dependent Protein Kinase and Inhibitor 
Reversible protein phosphorylation is involved in many processes that occur in 
the cell. The most important role of phosphorylation is regulatory mechanisms to 
respond to external stimuli or stress. cAMP dependent protein kinase (PKA) is one of 
the most well-studied of a very diverse protein kinase family. It is composed of two 
components, two regulatory subunits and two catalytic subunits, which dissociate upon 
activation by cAMP (48). Cooperative binding of cAMP to regulatory subunit triggers a 
conformational change that releases the catalytic subunits. The heat-stable protein kinase 
inhibitor (PKI) serves as a physiological inhibitor of the catalytic subunit. PKI is a small 
protein that is unstructured in solution (49). There are several tissue-specific and cell-
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cycle specific isoforms (50, 51). It binds to the catalytic subunit with high affinity (the 
dissociation constant = 0.2 nM), in the presence of ATP (52).However, PKI has a 
dissociation constant (Kd) of 230 nM in the absence of ATP (53). The tight binding of 
PKI in the presence of ATP also requires divalent metal ions (Mn(II), Mg(II)) to mediate 
interactions between ATP and side chains of the catalytic subunit (54).  
The inhibitory binding sites are localized at the N-terminus of PKI (positions 5-
24). The identification of this high affinity peptide fragment facilitated the crystal 
structure determination of PKA catalytic subunit-PKI complexes with 2.0-2.9 Å 
resolution (Figure 5A) (55-57). PKI is believed to be disordered in solution based on 
circular dichoism, fluorescence (58), and NMR (49) (Figure 5B). There are only two 
helical regions, 5-12 and 35-47. The N-terminal helix (inhibitory binding helix, 5-12, 
red) forms a hydrophobic patch (Tyr 7, Ile 11, Phe 10), which is important residues for 
tight binding to PKA catalytic subunit. The patche is followed by consensus Arg-rich 
sequences (Arg 15, Arg 18, and Arg 19) for active site binding (Figure 5B, pink) (59, 
60). This region undergoes confirmational changes upon binding to the catalytic subunit 
(49).  
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ATP 
PKI (5-24) 
 
Figure 5. Structure of cAMP-dependent protein kinase catalytic subunit complexed with 
protein kinase inhibitor peptide. 
(A) The strucutre of the PKA catalytic subunit (1ATP) with a bound PKI fragment (5-24) and ATP. The 
heat-stable PKI is shown as ribbon structure. (B) The tight inhibitory binding modif of the PKI fragment 
is represented in red, and conserved arginines (Arg 15, Arg18, and -Arg19) are in pink. 
 
 
 
Recently in Dr Bayley’s group, the interaction between a PKI fragment tethered 
to αHL and the PKA catalytic subunit was demonstrated in detail at single molecular 
level (61). The PKI polypeptide was attached to Thr129Cys of αHL pore, located near 
the trans mouth, by chemical modification. Ionic flow through the modified pore was 
monitored in single molecular level. Upon binding of the PKA catalytic subunit, 
transient blockade of electrical currents were observed. The dwell time, frequency, and 
amplitude of the blockade revealed a binding affinity of PKI to the PKA catalytic 
subunit with a comparable value to that obtained by traditional measurement. This 
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approach demonstrated another way to sense protein anlalytes at the single molecular 
level by using engineered αHL pores.  
 
Staphylococcus aureus 
Staphylococci are Gram-positive bacteria, which are normally found on the nasal 
passage or the skin of normal humans, and mammals (62). Based on the pigments 
produced by the bacteria, there are two species, Staphylococcus aureus (yellow) and 
Staphylococcus epidermidis (white). Staphylococcus aureus is the most commonly 
isolated species from affected rabbits and is a major cuase of hospital acquired infections 
of humans (63). It can be spread by direct contact or by aerosol and can reside in the 
nasal sinuses or lungs without showing any apparent disease. Even though the 
staphylococci infections are common, it usually retained at the entry points (skin, or 
nasal passage) by the host defense mechanisms. However serious infection can be 
caused through invasion to the blood stream, which quickly leads to skin lesions, 
infections in the lung, kidney, or heart. S. aureus produce many virulence factors which 
are mostly extracellular proteins that promote adherence, degrade host compounds, or 
damage host cells. The mechanism of pathogenesis for the disease caused by S. aureus is 
multifactorial (63). Therefore the mode of virulence factors is not yet fully understood.  
S. aureus express several different types of membrane-damaging toxins, which 
are probably serve as the mechanism for the host invasion. There are three types of 
toxins secreted, alpha, delta, and leukocidins. Some are hemolytic on susceptible cells 
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(platelets, monocytes) which do not correlate to the virulence in vivo. For example, 
leukocidins, which are found mostly in the severe dermonecrotic lesions, cause 
membrane damage to leukocytes, but they are not hemolytic (64).  
Other clinically important information about Staphylococci is the resistancy to 
various antibiotics with the hospital strains of S. aureus. The methicillin resistant 
Staphylococcus aureus (MRSA) develop drug resistance, which refer to “Superbug” 
(65). The mode for the drug resistance is by either mutation in the chromosomal 
mutation or by acquisition of extrachromosomal DNA inserts (transposons, plasmids), 
which is triggered by unknown factors. MRSA are responsible for the half of the 
hospital related infections (66). With more concern, S. aureus gained resistance to many 
common antibiotics, even the most powerful drug, vancomycin, within 60 years of 
penicillin introduction. Therefore urgent need for new drug molecules were evident to 
fight against MRSA. Recently, RNAII-inhibiting peptide (RIP) was tested on several 
animal models to test the inhibition of the MRSA strain infections (67). RIP is 
preventing the signal transduction pathway of the bacteria extracellular communication 
system (quorum sensing system), which is essential for the initial colonization of 
bacteria and for the downstream virulence factor activation (68, 69).  
 
Other Pore-forming Bacterial Toxins 
Membrane proteins, which span across the lipid bilayer to create a pathway for 
molecules across the membrane barrier, are usually referred to either pores or ion-
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channels. Strictly speaking, the ion-channels represent pores that are highly specific to a 
particular ion. On the other hand, the pores are lack of the permeant specificities. Here, 
the pores (mainly pore-forming toxins) will be discussed.  
 
 
Figure 6. Ribbon representation of PFT structures. 
The putative transmembrane domains are colored in blue (α-PFT) and in red (β-PFT). α-PFTs are (A) 
Colicin Ia, (B) Cry insecticidal δ-endotoxin, and (C) Diphtheria toxin. β-PFTs are (D) Proaerolysin 
monomer from Aeromonas hydrophila, (E) CytB δ-endotoxin dimmer from Bacillus thuringiensis, and (F) 
α-hemolysin heptamer from Staphylococcus aureus. All figures were generated by SPOCK.  
 
 
 
 
Based on the structural feature of the transmembrane domain, pore-forming 
toxins (PFTs) are classified into two types, α-PFTs and β-PFTs, which are composed of 
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alpha helices and beta-barrel, respectively. Some of the α-PFTs are colicin (Figure 6A) 
from various E. coli (70), insecticidal δ-endotoxin (Figure 6B) from Bacillus 
thuringiensis (71), and diphtheria toxins (Figure 6C) from Corynebacterium diphtheriae 
(72).Also an apoptic protein of Bcl-2 family forms a pore in similar mechanism as α-
PFTs (73). The other pore-forming toxins are β-PFTs. These toxins are mainly 
composed of β-sheets. Aerolysin (Figure 6D) from Aeromonas species (74), Bacillus 
thuringiensis CytB δ-endotoxin (Figure 6E) (75) and Staphylococcus aureus α-
hemolysin (Figure 6F) are some of the β-PFTs.  
These PFTs are secreted as water-soluble monomeric forms and then targeted to 
the susceptible cells using the host cell surface molecules (sugar, protein, or lipids) as 
their receptor. It is generally thought that the receptors serve as anchor to concentrate the 
toxins on the cell surface, and further facilitate the toxins to oligomerize and finally 
puncture holes in the membrane. The transmembrane domain of α-PFTs is hydrophobic 
which is hidden inside of the protein at the water-soluble state. However the 
transmembrane domain of β-PFT is amphiphillic. Therefore during the pore-forming 
step, it is logical to assemble as oligomers and enclose the polar edges of β-hairpins to 
generate a β-barrel. The actual mechanisms of the transmembrane domain penetration to 
the lipid bilayer are not fully understood for α-and β-PFTs. For α-PFT, the α-helices 
spread over the membrane surface and then insert to the membrane, which is called the 
umbrella mode (76). For β-PFT, the membrane spanning pre-stem (β-hairpin) region 
form extensive hydrogen bonding to generate a β-barrel. A few structures of these PFT 
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are illustrated in Figure 6. 
Besides PFT and ion-channels, there are ionophores, which transports certain 
ions across the membrane. Ionophores are produced by bacteria to protect themselves 
against other bacteria. Therefore, they are used as antibiotics. There are two types for 
ionophores, carrier and channel. The carrier is the molecule encapsulate the ions and 
carry them from one side of the membrane to the other side of the membrane (Figure 
7A). The channel is the molecule that spans the membrane and transports ions (Figure 
7B). Valinomycin and Gramicidin are the best characterized carrier and channel type 
ionophores, respectively (Figure 7A,B).  
Valinomycin is a cyclic dodecadepsipeptides, cyclo[-(L-Valine-D-Lactic acid-L-
Valine-D-Hydroxy-isovaleric acid)3-] from Streptomyces, which carries selectively 
potassium ions across the membrane (77). The alternating amino acid and hydroxy acid 
sequences compose a bracelet shaped ring. The potassium ion is placed in the center of 
the cyclic peptide ring and coordinates with six carbonyl oxygens of the amino acids 
(Figure 7A) (78-80). On the other hand, the exterior surface of the valinomycin-K+ 
complex is hydrophobic, which facilitates the valinomycin to enter the lipid bilayer 
freely. By changing the sequence of the valinomycin resulting the ring expansion, larger 
ion specificity was introduced (81).   
Antibiotic gramicidin is secreted from Bacillus brevis to make channels on 
Gram-positive bacteria membrane for defense mechanism. It translocates monovalent 
cations specifically, such as H+, Tl+, and alkali metals (82), which is composed of 
alternating D and L amino acids. Two molecules of gramicidins form the channel, which 
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undergo alignment change for open and close state-transition (Figure 7B,C) (83).  
 
 
Figure 7. Diagrams of ionophores.  
(A) Catoon figure of typical carrier type ionophores transporting monovalent metal ions across the lipid 
bilayer. (B) Graphic model of a channel type (gramicidin) is depicted. Note that two molecules of 
gramicidin compose a channel. The open form is shown here. (C) Saggitical view of the gramicidin dimer. 
All the molecular graphics of gramicidin (1MAG) is prepared by SPOCK.  
 
 
  
18
Research Objectives  
The αHL pore is consisted with the water-filled cavity with dimensions ranging 
from 14 Å to 45 Å in diameter, with approximate volume of 32,600 Å3. Previously the 
pores have been successibly modified with one polyethylene polymer (3.5 kDa or 5.0 
kDa) at Ser 106 position. Furthermore from the examination of the prepore to the pore 
transition, the central cavity is accommodating seven chains of the prestem domain (25 
residues).  
In this present project, the proposal of the cavity capacity with polypeptide chain 
will be tested by genetic engineering, which will be further developed to introduce novel 
functions. For initial project, the capacity of the central cavity will be estimated to 
contain flexible Gly/Ser linker polypeptide sequences and the dynamics of the inserted 
Gly/Ser loops will be examined with the electrical current recordings through αHL 
pores. Then with these results, two different approaches will be attempted. One involves 
the mechanism of polypeptide chain inside of the lumen (temperature responsive phase 
change of elastin-like polypeptide) and the other involves the detection of protein 
analytes from outside of the lumen (protein kinase interaction with protein kinase 
inhibitor fragment). Long term goal of this research is to introduce a folded functional 
protein, probably enzyme, into the cavity for active transport, or compartmentation of 
substrate and product.  
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CHAPTER II 
MATERIALS AND METHODS 
 
Strains 
XL10-Gold ultracompetent cells (Stratagene, La Jolla, CA) were used as 
recipients for PCR- in vivo recombination. To prepare XL10-Gold competent cells, cells 
were streaked out onto 1% agar containing fresh Luria broth (LB, 1% w/v tryptone, 1% 
w/v NaCl, 0.5% w/v yeast extract) from a glycerol stock. After overnight growth at 
37°C, a single colony was inoculated into 100 ml LB media and and grown at 37°C for 
8-9 h until the OD600 reached 0.5. The cells were collected by centrifugation (1000 g), 
and resuspended in 10 ml ice-cold TSS solution (10% w/v PEG 8000, 5% v/v DMSO, 
25 mM MgCl2 in LB). The cells were aliquoted in 200 µl portions and immediately 
frozen in an ethanol-dry ice bath. Prepared competent cells were stored in –80°C and 
used within ~6 months. 
For plasmids with repetitive DNA sequences, Sure 2 supercompetent cells 
(Stratagene, La Jolla, CA) were used to reduce homologous recombination in vivo. Sure 
2 strains have recA, recB and recJ mutations, which provide a recombination-deficient 
phenotype.  
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Transformation 
Circularized DNA was transformed into cells using a heat shock protocol (84). 
Plasmid DNA (10-100 ng) was gently mixed with 100-200 µl of freshly thawed 
competent cells. The cells were then incubated on ice for 30 min before heat shock at 
42°C for 30 s. The cells were transferred back into ice and incubated for 5 min. The cells 
(50-100 µl) were then plated on LB agar containing ampicillin (100 µg/ml). 
 
DNA Analysis and Isolation  
DNA was analyzed by agarose gel electrophoresis. Electrophoresis was carried 
out in a Tris/borate/EDTA buffer in agarose gels (1% or 2% (w/v)) containing ethidium 
bromide (5 µg/ml). DNA was visualized by illumination on a short wave UV light box. 
Small scale DNA isolation was carried out using the QIAprep Spin Miniprep Kit 
(Qiagen, Valencia, CA). A 10 ml culture was grown to saturation, for 12-16 h at 37°C, 
harvested and processed according to the manufacturer’s instructions. Miniprep DNA 
was used for restriction digests and sequencing when screening for clones. Large scale 
DNA isolation was carried out using a Qiagen Maxiprep Kit. A 200 ml culture was 
grown to saturation (12-16 h at 37 ºC), harvested and processed according to the 
manufacturer’s instructions. Plasmid DNA was quantitated by measuring the A260 of 
100-fold diluted DNA in water ([DNA] = A260 • 100 • 50 µg/ml). The concentration of 
DNA was adjusted to 400 µg/ml and the plasmid was stored at -20°C. Maxi prep DNA 
was used for in vitro transcription/translation reactions or for sub-cloning. 
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DNA fragments from PCR reactions and restriction digests required gel 
purification. If the wanted DNA fragment length was longer than 70bp, samples were 
resolved in an appropriate percentage agarose gel containing ethidium bromide. Any 
DNA fragment shorter than 70bp (DNA coding the repeat unit for Gly/Ser loop mutant) 
was resolved in a 20% polyacrylamide gel followed by staining with ethidium bromide. 
Gel slices containing the desired DNA fragments were excised over a long wave UV 
light source to minimize DNA damage. DNA was extracted from the gel slices (agarose 
or polyacrylamide) using the QIAquick Gel Extraction Kit (Qiagen, Valencia, CA). 
 
 
Figure 8. Generation of pT7-WM102 and its restiction enzyme map. 
(A) PCR-in vivo recombination was used to generate pT7-WM102, which contains unique MscI and MluI 
sites. Mutagenic primer dM102-1(red with notch) and non-mutagenic primer uNM-2 (red) were used to 
incorporate a MluI site into NdeI-linearized pT7-WT αHL. Mutagenic primer uM102-2 (blue with notch) 
and a non-mutagenic primer (dNM-1, blue) produced the N-terminal half of the αHL gene with MscI site, 
on  HindIII-linearized pT7-WT αHL template. (B) Restriction map of the resulting vector (pT7-WM102) 
is illustarated. Only the enzyme sites that are relevant for this work are shown. The newly incorporated 
MscI (blue) and MluI sites (red) are flanking the Ser 106 position of the αHL gene.  
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Mutagenesis 
Incorporation of new restriction enzyme sites near the insertion position of the Gly/Ser 
loop coding DNA  
Individual MscI and MluI sites were introduced into the central region of the 
αHL gene by a recombination-PCR protocol (85). In vivo recombination takes 
advantage of the fact that, if a plasmid is amplified as two overlapping separate halves, 
these halves can be assembled by E. coli, if the complementary ends are of sufficient 
length. Two sets of PCR were performed on the pT7-WT αHL template  (Figure 8) (86). 
Mutagenic primer dM102-1 (red with notch) and non-mutagenic primer uNM-2 (red) 
pair was used for PCR on NdeI-linearized pT7-WT αHL, generating 3’ half of the 
plasmid (Table 1). For the other half of the plasmid, mutagenic primer uM102-2 (blue 
with notch) and non-mutagenic primer dNM-1 (blue) were used on the HindIII-
linearized pT7-WT αHL template. The overlaps of the mutagenic primers and the non-
mutagenic primers wer 12 bp and 23 bp, respectively. The Expand high fidelity 
polymerase (Roche, Indianapolis IN) was used to minimize PCR induced errors. Each 
reaction contained water (40.5 µl), 10x reaction buffer (5 µl), 10 mM dNTP mix (1 µl), 
100 mM primers (1 µl each), template (2 µl) and Expand polymerase (0.5 µl). The 
reactions were heated for 2 min at 94ºC, prior to polymerization reactions. PCR 
conditions were 20 cycles of denaturation at 95°C for 2 min, annealing at 52°C for 30 s, 
and polymerization at 72°C for 1 min. A final incubation at 72ºC for 5 min was included 
to ensure the extension was complete. 
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TABLE 1. List of plasmids and primers for generation of Gly/Ser loop-containing αHL. 
Plasmid/ 
primer Description of construct Reference 
pT7-WT αHL T7 vector with wild-type alpha-hemolysin gene (αHL) (86) 
pT7-WM102 Y102W, M113A, and K288E point mutation on αHL gene, pT7 vector background In this work 
pT7-L(10n+5) 
Gly/Ser loop insertions in between N105 and S106 residues,  n=number of 
repeat units (SGSGSGGSGS) 0, 1, 2,…, 9, 10, 14 or 21, pT7-WM102 
background 
In this work 
pT7-WT αHL D4 Wild type αHL with a tail of four aspartates on the C terminus (87) 
dNM-1 5’-ATAAAGTTGCAGGACCACTTCTG-3’ (87) 
uNM-2 5’-CAGAAGTGGTCCTGCAACTTTAT-3’ (87) 
dM102-1 5’-TCGATTGATACAAAAGAGTAcgcGtcTACTTTAACTTATGGA-TCC-3’ In this work 
uM102-2 5’-TGTATCAATCGAATTTCTTGGccAGTAATCAGATAT-TTGAGCTAC-3’ In this work 
Footnote: underlining indicates the newly introduced MluI and MscI sites in dM102-1 and uM102-2, 
respectively (Figure 8). The small letters denote base changes.  
 
 
The PCR products were mixed together and used to co-transform E. coli XL10 
Gold (Stratagene, La Jolla, CA). The cells were grown for 16 h on LB-ampicillin plates. 
Colonies were picked and the DNA was isolated. MluI digestion was used to screen for 
the new MscI and MluI-containing vector (pT7-WM102). The entire αHL gene in pT7-
WM102 was sequenced to confirm the mutation. A fortuitous Lys-288 to Glu mutation 
was discovered, which later proved useful for the separation of heteromeric pores. 
Positive clones were transformed back into XL-10 Gold cells and large scale plasmid 
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preparations were made. To revert this mutation, Lys-288Glu, in pT7-WM102 and the 
genes encoding the loop-containing mutants, a gel-purified NdeI-MfeI fragment of each 
construct was inserted into a vector comprising the large NdeI-MfeI fragment (~4.3 kb) 
of pT7-WT αHL. All the revertants were sequenced. 
 
 
Figure 9. Diagram of Gly/Ser loop-containing αHL gene. 
Schematic of the L subunits. The glycine-serine loops were inserted before residue Ser-106. 
 
 
Construction of Gly/Ser-loop containing alpha-hemolysin genes 
Genes encoding alpha hemolysin subunits containing various length of Gly/Ser-
rich loops were constructed in three steps; Generation of the repeat unit, 
concatemerization of repeats, and ligation into the αHL gene. The loop-containing 
subunits (L) were designated by the length of inserted polypeptide chain (10n+5, where 
n is the number of repeat units) (Figure 9). The first loop-containing mutant, L15, was 
generated by ligation of two double-stranded oligonucleotides, formed from the single 
strands YI001, YI002, YI003 and YI004 (Table 2), into the vector pT7-WM102 from 
which the central MscI-MluI fragment had been removed, as illustrated (Figure 10). This 
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DNA encodes the amino acid sequence PRNGGGSGSGSGGSGSSGSIDTKEYA, where 
the exogenous Gly/Ser loop sequence is in italics. The AvaI sites, which flank the repeat 
unit, are underlined in the oligonucleotide sequences. 
 
TABLE 2. List of synthetic oligonucleotides used for L15 generation and concatemer 
formation. 
DNA Sequence Description 
YI001 5’-CCAAGAAATGGCGGGGGCTCGGGGTC-CGGAAGCGG-3’ 
5’ half for Gly/Ser loop of L15 mutant 
(sense). AvaI site is underlined 
YI002 5'-CGGATCAGGCTCCTCGGGTTCGATTGATA-CAAAAGAGTA-3’ 
3’ half for Gly/Ser loop of L15 (sense) with 
AvaI site (underlined), 5’-phosphorylated 
YI003 5’-CGCGTACTCTTTTGTATCAATCGAACCCG-AGGAGCCT-3’ 
5’ half for Gly/Ser loop of L15 (antisense) 
with AvaI site (underlined), 5’-
phosphorylated 
YI004 5’-GATCCGCCGCTTCCGGACCCCGAGCCCCC-GCCATTTCTTGG-3’ 
3’ half for Gly/Ser loop of L15 (antisense), 
AvaI site is underlined 
AC003 5’-TCGGGTTCGATTGATACAAAAGAGTA-3’ ‘Cap’ DNA, sense strand, 
AC004 5’-CGCGTACTCTTTTGTATCAATCGAAC-3’ ‘Cap DNA, antisense strand 
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Figure 10. Construction of αHL genes containing concatemeric DNA sequences 
encoding internal polypeptide loops.  
To introduce MscI and MluI sites for cassette mutagenesis, Y102W and M113A mutations were 
introduced by PCR-in vivo recombination. The K288E mutation was fortuitously generated during this 
process. The resulting vector, pT7-WM102, was digested with MscI and MluI, and then ligated with a 
synthetic duplex encoding PRNGGGSGSGSGGSGSSGSIDTKEYA. The italics indicate the inserted 
Gly/Ser-loop of mutant L15. The underlined red nucleotides indicate non-palindromic AvaI sites. The 
repeat unit was purified after AvaI digestion of L15. Tandem ligation of the repeat was performed in the 
presence of unphosphorylated cap oligonucleotides to control concatenation (cap to repeat, 1: 20). 
Concatemers were purified and ligated to a vector comprising the L15 plasmid from which the AvaI-MluI 
fragment had been removed. The nomenclature of the L subunits is L(10n+5), where n is the number of 
repeat units. 
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A substantial amount of the repeat unit (~0.5µg) was prepared by AvaI digestion 
(300 U) of the L15 plasmid (170 µg DNA, 37°C for 16 h), followed by TBE-
polyacrylamide gel purification. The cap DNAs were AC003 (sense) and AC004 
(antisense), which code GSIDTKEYA (Table 2). The initial Gly is an additional 
exogenous residue. The remaining amino acids are from the wild-type sequence except 
for the final Ala, which is from the mutation Met-113 to Ala mutation. The repeat unit 
was mixed with “cap” DNA (the cap to repeat molar ratio was 1:20) and T4 DNA ligase 
(400 U), and incubated at 16°C for 16 h (Figure 10). The cap oligonucleotides served to 
control the length of the concatemers, and to allow direction cloning without self 
ligation. A series of DNA concatemers was generated by tandem ligation of purified 
repeat units in the presence of cap oligonucleotides (Figure 11). Head-to-tail 
oligomerization was ensured by flanking the repeat units with non-palindromic AvaI 
sites (88,89). The cap duplex was unphosphorylated to prevent dimerization.  
The concatemers were purified from preparative 2.5% agarose gels by using the 
QIAEX II gel extraction kit procedure (Qiagen, Valencia, CA). The concatemers (~10 
pmol) were ligated into a recipient vector (100 to 150 fmol) prepared by digestion of the 
pT7-L15 plasmid with AvaI and MluI. The ligated products were transformed into E. 
coli Sure2 cells (Stratagene, La Jolla, CA), to prevent corruption of the repetitive genes 
by recombination. The constructs were screened by MscI and MluI digestion. Despite 
repeated attempts, L85 was not formed in this process and it was eventually produced by 
limited digestion of L105 with AvaI (0.2 U/ µg DNA, 37°C, 1 h), followed by 
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purification of the 8-fold repeat and its ligation into the recipient vector (100 to150 fmol 
of the pT7-L15 plasmid’s AvaI-MluI fragment) in the presence of cap DNA (2 pmole). 
All DNA ligation reactions were performed with 400 U of T4 DNA ligase (New 
England Biolabs, Beverly, MA) for 16 h at 22°C in 20 µL buffer, unless otherwise 
indicated. DNA was sequenced by Lone Star Labs Co. (Houston, TX). Synthetic 
oligonucleotides were produced by Integrated DNA Technologies (Coralville, IA).  
 
 
 
 
 
 
Figure 11. Generation of vectors for subcloning of the ELP repeat unit and the ELP 
containing-αHL.  
(A) PCR- in vivo recombination for elimnation of intrinsic EarI sites iin pT7-WT αHL D4 plasmid. Four 
mutagenic primers were used to remove EarI sites located at 198bp and 2002 bp in the plasmid. YH001 
(red, antisense) and YH003 (red, sense) primers were used in HincII-linearized pT7-WT αHL D4 
template, while YH002 (blue, sense) and YH004 (blue, antisense) primers were used for EcoRI-linearized 
template. (B) Plasmid pYH1- EC D4 was generated to accommodate ELP concatemers using EarI and 
MlluI sites. Duplex DNA (EC001 and EC002) were ligated into the vector, pYH1-L5 D4 plasmid 
prepared by AvaI digestion, to produce the recipient vector pYH1-EC D4.  
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TABLE 3. List of primers and plasmids used for constructing the ELP-containing αHL 
genes. 
Primer/
Plasmid Description Sequence 
YH001 Reverse mutagenic primer to remove intrinsic EarI site (underlined, 198 bp position) from pT7-WT αHL D4  
5’-ATACTCATACTaTTCC-
TTTTTCAA-3’ 
YH002 Forward mutageneic primer, which is comprementary to YH001 5’-TTGAAAAAG-GAAtAGTATGAGTAT-3’ 
YH003 Reverse mutagenic primer to remove intrinsic EarI site (underlined, 2002 bp position of pT7-WT αHL D4) 
5’-CATCAGGCGCTaTTC-
CGCTTCCTC-3’ 
YH004 Forward mutageneic primer, which is comprementary to YH003 5’-GAGGAAGCGGAAtA-GCGCCTGATG-3’ 
pYH1-
WT αHL 
D4 
Plasmid containing αHL-D4 gene in T7 vector with two EarI sites 
(198bp, 2002bp) removed.  
pYH1-
EM  
Subcloning vector to generate the elastin repeat unit (ELP; 
VPGGGVPGGGVPGGGVPGGGVPGGG)  
pYH1-
EC D4 Recipient plasmid for ELP concatemers using EarI and MluI sites  
pYH1-
E(5n) D4 
Plasmid containing αHL D4 gene with tandem repeats of ELP 
between position 105 and 106 of αHL, n= number of repeat units (1, 
2, or 4) 
 
Footnote: The small letters in mutagenic primers indicate the base changes into the templates. 
 
Preparation of the recipient vectors for the ELP repeat unit and the ELP concatemers 
Intrinsic EarI sites of pT7-WT αHL D4 were removed by PCR in-vivo 
recombinations (Figure 11) (85). The mutagenic primers were YH001 (red, antisense) 
and YH003 (red, sense) for EarI site (position 198 bp) removal, and YH003 (blue, 
antisense) and YH004 (blue, sense) for EarI site removal (position 2002 bp) (Table 3). 
The PCR fragments were overlapping by 23 and 24 bp, respectively. The first PCR was 
performed with 150 ng of linearized pT7-WT αHL D4 (87) (a kind gift from Dr S. 
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Cheley) by HincII, as the template, 50 pmol each of YH001 and YH003 primer, 0.5 mM 
dNTP, 2.5 U of Expand Long Template PCR enzyme mixture (Roche Applied Science, 
Indianapolis, IN), 1.75 mM MgCl2, and 1× Expand Long Template PCR enzyme buffer 
(Roche Applied Science, Indianapolis, IN) in a 50 µL reaction volume. The second PCR 
was performed with 150 ng of linearized pT7-WT αHL D4 by EcoRI, as the template 
and YH002 and YH004 as mutagenic primers. The amplification reaction consisted of a 
2 min cycle at 95ºC followed by 20 cycles of 95ºC for 1 min, 50ºC for 30 s, 72ºC for 1.5 
min for amplification, and a final extension at 72ºC for 5 min performed on a 
RoboCycler temperature cycler (Stratagene, La Jolla, CA). The PCR products were 
mixed together (5 µL each) and used to co-transform E. coli XL10 Gold (Stratagene, La 
Jolla, CA). The cells were grown for 16 h on LB-ampicillin plates. EarI digestion was 
used to screen for elimination of the EarI sites (198 bp and 2002bp postion). Then the 
sequence of the plasmid was confirmed by sequencing the plasmid. The resulting final 
plasmid was named pYH1-WT αHL D4 (Table 3). 
The central NdeI-MfeI fragment (~800 bp) of pT7-L5 was replaced by the 
internal fragment (~ 790 bp) of pYH1-WT αHL D4 to introduce AvaI, MscI, and MluI 
sites. The resultant (pYH1-L5 D4) was linearized with AvaI followed by insertion of 
DNA oligonucleotides (EC001, EC002) to introduce an EarI site inbetween the AvaI 
sites (Table 4). The resulting vector (pYH1-EC D4) was sequenced and stored at –20ºC.  
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TABLE 4. List of oligonucleotides used for generation of tandem ELP repeats. 
DNA Sequence Description 
EM001 5’-TATGAACTCTTCCGTACCCGGAGGTGGCGTGCC-AGGTGGCGGTGTCCA-3’ 
5’ half of elastin repeat unit 
(VPGGG)5, sense 
EM002 
5'-
GGTGGCGGAGTTCCAGGTGGAGGCGTCCCTGGCG-
GAGGTGTATGAAGAGCTA-3’ 
3’ half of elastin repeat unit, sense, 
5’ end phosphorylated 
EM003 5’-GCCACCTGGGACACCGCCACCTGGCACGCCACC-TCCGGGTACGGAAGAGTTCA 
5’ half of elastin repeat, antisense, 
5’ end phosphorylated 
EM004 5’-AGCTTAGCTCTTCATACACCTCCGCCAGGGACGC-CTCCACCTGGAACTCC 3’ half of elastin repeat, antisense 
EC001 5’-TCGGGGGTATGAAGAGAGCAGATGCATGGC-3’ Complementary strand of EC002 
EC002 5'-CCGAGCCATGCATATGCTCTCTTCATACCC-3’ Incorporation of EarI site (underlined) on antisense strand 
ETCAP001 5’-GTAGGAGGCTCCTCGGGTTCGATTGATACAAAA-GAGTA-3’ 
Cap DNA for ELP concatemers, 
sense strand 
ETCAP002 5'-CGCGTACTCTTTTGTATCAATCGAACCCGAGG-AGCCTCC-3’ 
Cap DNA for ELP concatemers, 
antisense strand 
 
Generation of a construct coding a monomermic ELP repeat unit 
The monomeric repeat unit coding plasmid (pYH1-EM) was generated by 
ligation of two double-stranded oligonucleotides formed from synthetic DNAs, EM001, 
EM002, EM003, and EM004 (Table 4), into the vector pYH1-WT αHL D4 from which 
the central NdeI-HindIII fragment had been removed (Figure 11). Prior to ligation to the 
vector, 5’ ends of EM002 and EM003 DNA were phosphorylated by T4 polynucleotide 
kinase (New England BioLab, Beverly, MA), followed by heat inactivation of the 
enzyme (65ºC for 20min). These DNAs encode the five tandem-repeats of VPGGG. The 
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EarI sites, which flank the repeat unit, are underlined in the oligonucleotide sequences. 
The ligated product was transformed to Sure2 ultracompetent cells (Stratagene, La Jolla, 
CA) to prevent any unwanted in vivo recombination. The resultanting plasmid was 
purified and sequenced.  
 
 
 
Figure 12. Construction of ELP-containing αHL gene. 
DNA encoding five repeats of VPGGG was first subcloned into the pT7 vector. The purified repeat unit 
was then concatemerized in the head-to tail direction in the presense non-phosphorylated cap DNA. The 
concatemers (1, 2, and 4 repeat units) were then purified and ligated to the final recipient vector pYH1-
EC-D4 with EarI and MluI. 
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Construction of αHL gene with tandem repeats of ELP 
A series of DNA concatemers was generated by tandem ligation of the purified 
repeat unit in the presence of cap oligonucleotides (Figure 12) Concatemers were 
prepared by ligation reaction (16ºC, 16 h) of purified repeat unit and unphosphorylated 
cap DNA (1:20 molar ratio = repeat unit/cap) as demonstrated for Gly/Ser-loop 
containing αHL.  Cap DNA encodes VGGSSGSIDTKEYA, and consists of  ETCAP001 
(sense) and ETCAP002 (antisense) DNA strands (Table 4). The italics indicate 
exogenous residues and normal letters are for endogenous residues of αHL, Ser-106 to 
Met-113Ala. Head-to-tail ligated concatemers with 1, 2 and 4 repeat units were purified 
from preparative 2.5% agarose gel followed by QIAEX II gel extraction kit procedures 
(Qiagen, Valencia, CA). 
The concatemers were ligated into a recipient vector prepared by digestion of the 
pYH1-EC plasmid with EarI and MluI (Figure 12). The ligated products were 
transformed into E. coli Sure2 cells (Stratagene, La Jolla, CA), to prevent corruption of 
the repetitive genes by recombination. The final constructs contained 5 residues of linker 
sequence upstream (GGGSG) and downstream (GGSSG) of the ELP sequence, ELP 
repeats (25, 50, 100 residues) and one additional valine residue at the end of ELP 
sequence. The ELP-containing αHL genes were denoted as E5, E10, E20, based on the 
number of  the pentapeptide VPGGG (i.e. 5, 10 and 20 repeats of VPGGG, respectively). 
At the C-terminus of the αHL gene, four residues of aspartate were added to facilitate 
separation of heteroheptamers (see below) (87). The αHL genes of all constructs were 
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sequenced by Lone Star Labs Co. (Houston, TX).  
 
Construction of an αHL gene with protein kinase inhibitor fragment encoded with the 
inserted loop 
Intrinsic SacI site removal from the vector.  
Intrinsic SacI site from the plasmid pYH1-WT αHL D4 was removed by Klenow 
fragment using 3’exonuclease activity. pYH1-WT αHL D4 was linearized with SacI 
(3810 bp). Klenow fragment (2.5U) (Stratagene, La Jolla, CA) was added to the sample 
and incubated at 37ºC for 1h. 3’ overhangs were digested by Klenow fragment 
exonuclease activity. Then, the Klenow enzyme was heat inactivated at 65ºC for 20 min. 
The modified DNA was cicularized with by T4 DNA Ligase (New England Biolabs, 
Beverly, MA) and then transformed in XL10-Gold competent cells. The transformed 
cells were pleated onto LB-Agar plate containing ampicillin for 16 h at 37ºC. Eight 
colonies were picked and regrown in 10 ml LB-ampicillin media for 16 h at 37ºC. Mini-
DNA preparation was performed to purify plasmids for screening by digestion with 
SacI. A positive plasmid (pYH2-WT αHL D4) was sequenced and collected from a large 
culture (100 mL). The αHL gene of pYH2-WT αHL D4 (NdeI-MfeI) was replaced by 
the equivalent fragment of pT7-L45 or pT7-L105. The resulting constructs (pYH2-L45 
D4 and pYH2-L105 D4) were isolated by mini-DNA preparation and screening by 
digestion with MluI, prior to sequencing and maxi-DNA preparation. 
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SacI-XhoI sites incorporation to the Gly/Ser loop. 
The introduction of unique SacI and XhoI sites to the very end of the repetitive 
Gly/Ser sequence was a challenging step. Every repeat unit ended with an AvaI site. 
Therefore simple digestion by AvaI would remove all the Gly/Ser repeats. According to 
the repetitive sequences of template, a novel attempt was initiated for PCR. Instead of 
using the ten Gly/Ser repeats as template to incorporate unique SacI and XhoI sites, the 
construct with half the size of the repeat (four repeats) was used to introduce either SacI 
or XhoI into 5’ end or 3’ end of the Gly/Ser repeats, repectively (Figure 13). Then these 
PCR fragments were ligated with DNA strands encording PKI fragment (5-24 postion), 
using SacI and XhoI (Figure 13). Conventially the 3’ ends of a mutagenic primer are 
designed to anneal to template, while the 5’ ends are used for incorporation of non-
complementing sequences. Here, 3’ end of the mutagenic primers were designed with 
only 5 bp complementing sequences. However, the 5’end of the mutagenic primers were 
designed to anneal to template with 21 or 24 bp complementing sequences, which anneal 
at outside of the Gly/Ser repeats (Figure 11).  
Mutagenic primers are SX001(blue, antisense) and SX002 (red, sense) and non-
mutagenic primers are SC001 (blue, sense) and SC011 (red, antisense) (Table 5, Figure 
13). The templates were NdeI-linearized pYH2-L45 D4 and pYH2-L105 D4, for 
generation of the C-terminal haves of the PKI loop-containing αHL genes, PKI115 and 
PKI225, respectively. For the N-terminal halves, HindIII-linearized pYH2-L45 D4 and 
pYH2-L105 D4 were used as template for PKI115 and PKI225, respectively (Figure 13).  
PCRs were perfomred at temperature using high temperature gradient (56ºC-65ºC) for 
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annealing step by Robo-Cycler (Staratagene, La Jolla, CA). To prevent any non-specific 
elongation, polymerase and antibody mixture (JumpStart AccuTaq DNA polymerase, 
Sigma, St Louis, MO) was used. At the initial step of denaturation, the antibody that is 
bound to polymerase dissociates and the polymerase is activated (90). The conditions for 
PCR were 15 cycles of denaturation for 1 min at 95ºC, annealing step for 30 s at 
temperature gradient (56ºC -65ºC) and extension for 1 min at 68ºC. The samples were 
then incubated at 68ºC for 5 min to ensure the extension. The PCR products  (852 bp and 
519 bp) were purified by QIAquick PCR purification kit (Qiagen, Valencia, CA).  
 
TABLE 5. List of primers and plasmids used for PKI (5-24) loop-containing αHL. 
Primer Sequence Description 
SC001 5’-CACTATAGGGAGACCACAAC-GG-3’ 
Non-mutagenic forward primer, incorporation of XhoI 
site 
SC011 5'-CCCCTCAAGACCCGTTTAGA-GGC-3’ 
Non-mutagenic reverse  primer, incorporation of SacI 
site 
SX001 5’-CCGAGAAATGGCGGGG-GCTCGaGtTCCGG 
Mutagenic forward primer for SacI (underlined) 
incorporation to 3’ end of the Gly/Ser repeats in pYH2-
L45 D4 
SX002 
5’-
CTCTTTTGTATCAATCGAGctcC-
CCGAGC 
Mutagenic reverse primer for XhoI (underlined) 
incorporation to 3’ end of the Gly/Ser repeats in pYH2-
L45 D4 
pYH2-L45 D4  Plasmid with L45 αHl gene in pT7 vector with intrinsic EarI and SacI sites were removed, D4 tail on C-termini 
pYH2-L105 D4  Plasmid with L105 αHl gene in pT7 vector with intrinsic EarI and SacI sites were removed, D4 tail on C-termini 
pYH2-P115 D4  
Plasmid withPKI loop containing  αHL gene (Y102W, 
M113A),  The loop is 115 residue- long. D4 tail on C-
termini 
pYH2-P206 D4  
Plasmid withPKI loop containing  αHL gene (Y102W, 
M113A),  The loop is 206 residue- long. D4 tail on C-
termini 
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Figure 13. PKI fragment insertion to the Gly/Ser linker sequences.  
(A) To incorporate a SacI site at the 3’ end of the Gly/Ser repeats of L45 D4 gene, PCR was performed 
with non-mutagnenic primer SC001 and SX002 (light blue) with the template, HindII-linearized pYH2-
L45 D4. The PCR with SC011 (non-mutagenic primer, red) and SX001 (mutagenic primer, red) was 
performed to incorporate an XhoI site to the 5’ end of the Gly/Ser repeats of L45 D4 gene. The template 
was NdeI-linearized pYH2-L45 D4. The PCR products (light blue and red) was ligated with the DNA 
(yjPKI001-004) encoding PKI fragment (5-24) followed by second PCR with SC001 and SC011. The 
resulting PCR product was then subcloned into TA-TOPO vector, followed by final cloning into pYH2-
EC D4 vector prepared by NdeI and HindIII digestion. The final construct is denoted as pYH2-P115 D4, 
which encodes the αHL gene with PKI-containg loop. (B) The same procedures were taken to generate 
the final construc pYH2-P206 D4. The template was either HindIII-linearized pYH2-L105 D4 or NdeI-
linearized pYH2-L105 D4 for the N-terminal half or the C-terminal half, respectively, of the P206 D4 
gene. The final P206 D4 gene is shown in B. Initially the DNA encoding PKI fragment was to place at the 
middle of the exogenous loop sequence. But during the transformation, four repeats of Gly/Ser repeat unit 
was lost. 
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TABLE 6. List of oligonucleotides used for PKI loop containing αHL genes. 
DNA Sequence Description 
yjPKI001 5’-TATGAGCTCAGGATCGACGACCTATGCAGATTTTATCG-CATCCGGG-3’ 5’ half of PKI fragment, sense 
yjPKI002 5'-CGTACCGGTCGTCGCAATGCAATCCATGATGGAAGCGG-ATCAGGCTCCTCGAGTA-3’ 
3’ half of PKI fragment, sense, 
5’ end phosphorylated 
yjPKI003 5'-ACGCCCGGATGCGATAAAATCTGCATAGGTCGTCGATC-CTGAGCTCA-3’ 
5’ half of PKI fragment, 
antisense 
yjPKI004 5'-AGCTTACTCGAGGAGCCTGATCCGCTTCCATCATGGATT-GCATTGCGACGACCGGT-3’ 
3’ half of PKI fragment, 
antisense, 5’ end 
phosphorylated 
 
 
PKI fragment (5-24) insertion to the Gly/Ser linker sequences. 
DNA fragments (yjPKI001, 5’-phosphorylated yjPKI002, 5’-phosphorylated 
yjPKI003, and yjPKI004) coding PKI fragment (5-24) were ligated between two PCR 
products (Figure 14) by T4 DNA ligase (400U, 1X buffer, 20 µL) using newly 
introduced SacI and XhoI sites (Table 6). Since each PCR product was from same 
number of Gly/Ser repeats (total 45 residues), the PKI fragment would be placed at the 
mid-point of the loop. Because of low yield of three-way ligation, a second set of 
amplification was performed using 10 cycles of PCR. The PCR conditions were the 
same as the first reaction condition except the primers and annealing temperautre. The 
primers were SC001 (sense) and SC011 (antisense) and the annealing temperature was 
53ºC. The product was ligated into TOPO-TA cloning vector (pCR2.1-TOPO) according 
to the manufacturer (Invitrogen, Carlsbad, CA). The topoisomerase I from Vaccinia 
virus ligates the 3’ overhang A base, which is inserted by nontemplate-dependent 
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terminal transferase activity of Taq polymerase, to the topo-TA vector (91). The 
circularized vector was transformed into Sure2 competent cells, instead of OneShot cells 
supplied with topo-TA kit, to minimize unwanted recombination of repetitive sequences. 
The transformed cells were spread over LB-agar-ampicillin plate at 37ºC for 16 h. Single 
colonies were picked and grown in an LB-ampicillin medium (10 ml) for 16h for screen 
of positive clones. Plasmids were purified from the cultured cells and digested with AgeI 
for screening. Positive clones (4 samples) were sent for sequencing. According to the 
sequence results, there were recombination of Gly/Ser repeats on pYH2-P215 D4 
construct in all picked clones, resulting in a shorter total loop length (206 residues) and 
PKI fragment was located at slightly towards the C-terminus (Figure 13). The resulting 
construct was called as pYH2-P206 D4, due to the shortened loop length. There were no 
unwanted errors for pYH2-P115 D4 constructs.  
 
 
Rabbit Red Blood Cell Membrane Purification  
Rabbit red blood cell membranes (rRBCM) were prepared by hypotonic lysis of 
purified rabbit erythrocytes. After repeated washings of the lysed cell with 150 mM 
NaCl, 10 mM MOPS, pH 7.4, containing 1 mg/ml BSA, the membrane fraction was 
collected and suspended in 10 mM MOPS, 150 mM NaCl pH 7.4, containing 1 mg/ml 
bovine serum albumin (MBSA) at concentration of ~2.5 mg protein/ml. The 
concentration of membrane protein was determined with the DC-Protein Assay kit from 
Bio-Rad (Hercules, CA). rRBCM were stored in –80˚C until ready to use. 
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Preparation of Soluble Monomeric Subunits 
Radiolabeled monomeric wild-type or mutant αHL polypeptides were 
synthesized by coupled in vitro transcription and translation (IVTT) in the presence of 
[35S]methionine (10 µCi per 25 µL reaction, 1200 Ci/ mmol, ICN, Irvine, CA) and 
rifampicin (20 µg/ ml), with an E. coli T7 S30 extract System (Promega, Madison, WI) , 
as described previously (14). To inhibit transcription by E. coli RNA polymerase, the 
S30 extract was pretreated with 20 µg/ml rifampicin.  A 25 µl reaction contained: 400 
µg/ml DNA template (4 µl), amino acid mix minus methionine (2.5 µl), premix (10 µl), 
[35S]methionine (1 µl, 10 µCi), S30 extract (7.5 µl). The mixture was incubated at 37°C 
for 1 h. The reactions were analyzed on a 10% SDS-polyacrylamide gel, which was 
fixed for 1 h in destaining solution (40% methanol, 40% acetic acid, 20% water) and 
then dried. The dried gel was visualized after exposure to BioMax MR film (Kodak, 
Rochester, NY) overnight. 
 
 42
 
Figure 15. Flowchart of αHL oligomer formation. 
αHL oligomer can be prepared by two ways: co-IVTT/oligomerization or sequential IVTT and 
oligomerization. With co-IVTT/oligomerization method, the templates can be either a plasmid coding 
wild type or mutant αHL, for homoheptamer generation. Or for heteroheptamers, mixtures of plasmids 
under various ratios were used. The assembled oligomer pellet was collected by centrifugation followed 
by washing away partially bound or non-specific bound proteins with MBSA buffer. The membrane pellet 
was resuspended in MBSA buffer and subjected for next step of analysis (electrophoresis, proteolysis, or 
thermal stability assay). With sequential method, first monomeric αHL (wild-type or mutant αHL) was 
prepared then assembled by mixing with purified rabbit erythrocyte membrane. For heteromers, various 
ratios of monomers were used. The rest of the steps were identical to co-IVTT/oligomerization method. 
 
 
 
 
Oligomer Formation and Purification 
Homoheptamer preparation 
Radiolabeled membrane-bound wild-type or mutant αHL homoheptamers were 
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generated by coupled in vitro transcription and translation (IVTT) in the presence of 
rabbit red blood cell membranes (rRBCM), by using the S30 extract kit from Promega 
(Madison, WI) (29).Template DNA (1.6 µg) encoding either the wild-type αHL subunit 
(W), or an insertion mutant of αHL (L, E, or P) was incubated with rRBCM (5 µL, 2.5 
mg/ ml membrane protein) and IVTT components, in the presence of [35S]methionine 
(10 µCi) (Figure 15). To inhibit the intrinsic E. coli transcription, S30 mix was 
pretreated with rifampicin (20 µg/ ml). After 1 h at 37ºC, membrane pellets were 
collected and washed twice with MBSA (10 mM MOPS, pH 7.4, 150 mM NaCl, 1 mg/ 
ml BSA). The washed pellet was resuspended in MBSA (40 µL), prior to the addition of 
2X Laemmli sample buffer (40 µL) (92). A portion of the sample (20 µL) was resolved 
in a 5% SDS-polyacrylamide gel. The sample was not heated, which would dissociate 
the subunits. The yield of oligomers was determined by phosphorimager analysis 
(Molecular Imager FX; Bio-Rad, Hercules CA, OptiQuant; Packard Instrument, 
Meriden, CT), by comparison with αHL wild-type heptamer standards run in parallel 
(93). The specific radioactivity of wild-type αHL was calculated based on the 
assumption that the specific hemolytic activity is 25 ng/ mL (86). Because no additional 
Met codons were introduced in the mutagenesis procedure, no correction for the number 
of methionine residues was required for the insertion mutants. Autoradiographs or 
phosphorimages were generally obtained after overnight exposure, unless otherwise 
indicated. For example, the gels with L25 homoheptamers were exposed for 21 d and 2 d 
for autoradiograms and phosphorimages, respectively. 
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Heteroheptamer preparation 
To obtain radiolabeled heterooligomers, template DNA encoding the wild-type 
subunit and the insertion mutant were mixed in various ratios (W/ L (E or P) = 4: 0, 3: 1, 
1: 1, 1: 3, and 0: 4) prior to IVTT.  As shown previously (29), the presence of rRBCM 
during IVTT allowed the newly synthesized protein to assemble into oligomers . The 
IVTT reactions were carried out for 1 h at 37˚C with the molar ratios of template DNA 
indicated, in the presence of [35S]methionine and rRBCM (5 µL, 2.5 mg protein/ml). The 
resulting membrane-bound heterooligomers were solubilized and purified as described 
for the homooligomers (Figure 15). 
 
Heptamers for single channel recordings 
For αHL pores to be used in bilayer experiments, a complete amino acid mix was 
used in the presence of [35S]methionine to increase the yield of protein synthesis (Figure 
15) (29). The solubilized membrane pellet was immediately separated in a preparative 
5% SDS-polyacrylamide gel at 50 V for 16 h, with 0.1 mM Na thioglycolate in the 
cathode buffer. The gel was vacuum-dried at room temperature without fixing and 
exposed to X-ray film. Bands were excised from the gel by using the autoradiograph as a 
template. After rehydration, gel slices were crushed and soaked in water (500 µL) for 6 
to 8 h. The suspension was then filtered to remove gel debris by using a cellulose acetate 
spin filter (Rainin, Woburn, MA). The filtrates were stored at -80ºC until required.  
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Limited Proteinase Assay 
Membrane-bound loop-containing αHL pores (L57, L157, L257) were prepared in 
IVTT reactions (50 µl) in the presence of rRBCM. After 1 h at 37ºC, the membrane 
pellets were resuspended in MBSA (40 µL), and divided into four portions (9 µL each). 
Proteinase K (Roche Applied Science, Indianapolis, IN) solutions were prepared by 
dilution of a thawed enzyme stock (10 mg/ ml in water) and used immediately. Diluted 
enzyme solutions or water were added (1 µL) to the samples to give final proteinase K 
concentrations of 0, 5, 50, and 500 µg/ ml). After 5 min at 22°C, the reactions were 
stopped by treatment with phenylmethylsulfonyl fluoride (2 mM final, Roche Applied 
Science, Indianapolis, IN) for 5 min at 22°C, followed by the addition of 2× Laemmli 
sample buffer. The unheated samples were immediately resolved by electrophoresis in 
either 5% or 10% SDS-polyacrylamide gels. The intensity of residual bands were 
measured either by OptiQuant software (Packard Instrument, Meriden,CT) from 
phosphorimages or with ImageJ software (http://rsb.info.nih.gov/ij/, NIH, Bethesda, 
MD) for autoradiographs. 
 
Thermal Stability Assay of Membrane-bound Oligomers 
Radiolabeled heteromeric loop-containing αHL oligomers  (L5/W, L15/W, 
L25/W) were synthesized by co-translation of the wild-type αHL polypeptide (W) and 
loop-containing αHL (L) polypeptides in the presence of [35S]methionine and rRBCM. 
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Each washed membrane pellet obtained from translations with various molar ratios of 
templates (W:L = 4: 0, 3: 1, 1: 1, 1: 3, and 0: 4) was resuspended in 20 µL of MBSA. 
The samples were pooled, and mixed with an equal volume of 2× Laemmli buffer, and 
then divided into five portions (40 µL each). Each sample was overlaid with mineral oil 
to prevent evaporation. The samples were incubated at 22°C, 56°C, 59°C, 62°C or 65°C 
for 5 min in a Robocycler (Stratagene, La Jolla, CA). The treated samples were 
immediately separated by electrophoresis in 5% SDS-polyacrylamide gels, followed by 
autoradiography. 
The radiolabeled homomeric loop-containing αHL oligomers (W7, L57, L157, 
L257) were synthesized in IVTT reactions (100 µl) in the presence of [35S]methionine 
and rRBCM. The washed membrane pellets were resuspended in 100 µL of MBSA, 
followed by the addition of an equal volume of 2X Laemmli sample buffer. The solution 
was then divided into five tubes (40 µL each) and incubated at 22°C, 47ºC, 50ºC, 53ºC 
or 56ºC for 5 min. Each sample was overlaid with mineral oil to prevent evaporation. 
The samples were separated by electrophoresis in 5% SDS-polyacrylamide gels, 
followed by autoradiography.  
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Figure 16. Illustration of planar bilayer recording apparatus with an αHL pore embedded 
in the lipid bilayer. 
A cartoon of a typical bilayer chamber is shown. Note that the cis side, to which the protein is added, is 
grounded. The cap domain resides in the cis compartment. 
 
 
 
 
Single-Channel Recordings 
Single-channel current recordings were performed with a planar lipid bilayer 
generated by the method of Montal and Mueller method (94). Briefly, a 100 to 150 µm-
diameter orifice in a 25 µm-thick Teflon film (Goodfellow Corporation, Malvern, PA) 
was prepared, which is separating the cis and trans compartments of the apparatus 
(Figure 16). The aperture was pretreated with 10% (v/v) hexadecane in n-pentane 
(Burdick & Jackson, Muskegon, MI). 1,2-diphytanoyl-sn-glycerophosphatidylcholine 
(Avanti Polar Lipds, Birmingham, AL) in highly pure pentane (Burdick & Jackson, 
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Allied Signal Inc., Muskegon, MI) was applied to both side of the compartment, 
followed by slowly elevating the solution in both compartment to generate planar lipid 
bilayer. Purified heptameric αHL pores (0.1 to 1.3 µg/ ml) were added to the cis 
compartment.  A potential difference was applied across the bilayer with Ag/AgCl 
electrodes in 1.5% agarose (Bio-Rad, Hercules, CA) containing 3 M KCl. The cis 
chamber was at ground, a positive potential indicates a higher potential in the trans 
chamber. The current was recorded by using a patch clamp amplifier, Dagan 3900A 
(Dagan Co., Minneapolis, MN). The signals were stored on a DAS-75 data recorder 
(Dagan Co., Minneapolis, MN). After filtering with a Bessel filter (Model 900, 
Frequency Devices, Haverhill, MA) at 10 kHz frequency, the signals were acquired at 3 
to 20 µs sampling intervals by a personal computer by using a Digidata 1200A or 1322 
A/D board and Clampex 8.0 software (Axon Instruments, Union City, CA). The data are 
presented by using Clampfit 9.2 (Axon Instruments, Union City, CA ) and Origin 6.2 
(Microcal Software Inc., Northampton, MA). 
 
SDS-PAGE Analysis  
Proteins were analyzed by the method of Laemmli (92). Briefly, a discontinuous 
system composed of a lower separating gel (375 mM Tris•HCl, pH 8.8, 0.1% SDS) and 
an upper stacking gel (125 mM Tris•HCl, pH 6.8) was electrophoresed in running buffer 
(25 mM Tris•HCl, 192 mM glycine, 0.1% SDS) at a constant voltage (50 V or 100 V). 
Monomeric αHLs (30 kDa to 66 kDa) were resolved in 10% acrylamide gel, while 
heptameric αHLs (≥220kDa) were resolved in 5% acrylamide gels without prior heating 
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to prevent disassembly of oligomers. Electrophoresis was carried out in a Gibco BRL 
vertical electrophoresis system (Gibco-BRL, Gaithersburg, MD). The gels were fixed in 
10% acetic acid, 40% methanol followed by drying at 80°C for analytical gels. 
Preparative gels were dried at room temperature without fixing. Autoradiograms of dried 
gels were obtained by exposure to X-ray films for 16 h, or to phosphor imaging screen 
for 1h. The images were analyzed by the software ImageJ (http://rsb.info.nih.gov/ij/, 
NIH, Bethesda, MD) and OptiQuant (Packard Instrument, Meriden, CT) or Quantity 
(Bio-Rad, Hercules, CA), respectively for autoradiograms and phosphoimages. 
 
Estimation of the Cavity Volume of the αHL Pore 
To determine the volume of the alpha-hemolysin cavity (Figure 17) by SPOCK 
6.3 (95), an enclosed surface was required. The top and bottom openings of the vestibule 
were blocked by placing solid planes parallel to the Lys 8 and Lys 147 rings (Figure 
17A, B). The software used to determine the volume cannot calculate the volume of the 
cavity directly, due to the large size of the αHL cavity. To overcome this, two additional 
planes were placed parallel to the 7-fold axis of the pore (Figure 17A). These planes 
isolate a “slice” of the cavity equivalent to 1/7 of the total volume. The solvent 
accessible surface of the αHL cavity was generated by rolling a probe with 1.4 Å 
diameter over the molecular surface.  Then the volume of a “slice” of the cavity (Figure 
17C) was calculated by SPOCK, followed by manual adjustment for the volume of the 
bounding plane.  The total cavity volume was calculated by multiplying the volume of 
the slice by seven. Eight different slices were defined by rotating the vertical planes in 
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10 degree increments at the center of 7-fold axis. These multiple observations were 
made to assess the variability of the measurement.  
 
 
 
Figure 17. Calculation of the cavity volume against the solvent accessible surface of the 
αHL pore.  
(A) The top (left) and the vertical (right) views of the αHL pore with the planes to enclose the central 
cavity. The horizontal planes were to seal the central lumen, and the vertical planes were to slice the 
cavity in 7-folds. (B) The positions where the horizontal planes were placed. (C) A slice of the cavity was 
arranged along the 7-fold vertical axis to demonstrate the calculation of the total cavity volume was 
obtained by multiplying each slice volume by seven. Manual adjustment was performed for the volume of 
the vertical planes. 
 
 
 
Representations of the αHL pores and monomeric αHL subunits were generated 
with SPOCK 6.3. Proposed model of loop-contained αHL (L15 subunit) was generated 
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by Swiss-Model (96). The PDB coordinates of these models were superimposed to one 
of the wild-type αHL subunit in heptameric pore.  
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CHAPTER III 
STUDY OF GLY/SER POLYPEPTIDE-CONTAINING ALPHA-
HEMOLYSIN PORES 
 
As for initial study work of the project, tandem repeats of flexible Gly/Ser linker 
sequence was placed to investigate the packing capacity of the polypeptide chain in the 
αHL cavity. To control the length of the insertion, Gly/Ser repeat sequences were used. 
Additionally, a given length of the Gly/Ser loop could be accommodated seven times, 
since the aHL pore is assembled by seven subunits. These insertion mutants (loop-
containing subunits, L) were assembled either by themselves to form homoheptamers or 
with wild-type αHL subunits to form heteroheptamers. The assembled oligomers were 
studied in detail to provide evidence that they are assembled into stable heptamers. In 
addition, the oligomers were purified and used to generate pores on bilayers, which were 
studied with single channel recording.  
The use of genetic engineering was evaluated with this initial study. The capacity 
of the cavity to contain polypeptide sequences was estimated. Furthermore, the dynamics 
of the inserted Gly/Ser loops were examined at single molecular level by observing 
current fluctuations through the αHL pore. These results provided fundamental 
informations for the next stage of the project, which was to place small functional 
peptides within the αHL pore. 
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Mutant αHL Genes Encoding Gly/Ser Loops 
The peptide bond upstream from position 106 in αHL was selected as the point of 
insertion for Gly/Ser concatemer sequences. The selection was based on structural 
information and previous mutagenesis studies (1, 6, 9, 16, 17, 20). Optimally, the side 
chains adjacent to the insertion position should be exposed to solvent in both the 
monomeric and heptameric states of αHL for minimum perturbation of assembly and the 
structure of the pore.  
 
 
 
 
Figure 18. Accessibility of side chains near the position of insertion. 
Ideally, if the side chains near the insertional position are exposed to the surface in both the monomeric 
(violet, left) and the heptameric state (blue, right). Therefore minimal perturbation would be caused after 
the loop insertion. The S106 position (yellow) is located near the widest region of equatorial axis of the 
pore. However, both N105 and I107 are partially facing the interior of the protein either in the monomeric 
or the heptameric state. 
 
 
 
In the heptameric pore, the side chain of the wild-type residue Ser-106 is facing 
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towards the water-filled lumen (Figure 18) (20). The Gln-105 side chain of the 
staphylococcal leukocidin F monomer (17) or the Lys-99 side chain of the 
staphylococcal leukocidin S monomer (9), which correspond to residue Ser-106 in αHL, 
are exposed to solvent as well (Figure 18). Additionally, in the αHL pore, Ser-106 is 
located near the widest region of the cavity, again facilitating polypeptide insertion into 
the αHL backbone. In previously, polymers were tethered at position 106 without 
perturbing assembly (8, 97). Furthermore, other residues (position 104-108) located near 
the widest region of the cavity influenced function when cysteine mutations were 
performed (20, 98, 99) or proved to be interacting with other residues either in the 
monomeric or the heptameric state (1, 100). Therefore the position 106 would be the 
ideal postion for loop insertion.  
Glycine and serine residues are useful amino acids for the construction of linkers 
(loops) between domains; the hydrophilic serine side chain allows hydrogen bonding to 
solvent water and glycine provides the necessary flexibility (9, 101). To generate the first 
loop-containing αHL mutant L15, a synthetic oligonucleotide encoding 
PRNGGGSGSGSGGSGSSGSIDTKEYA (the exogenous Gly/Ser-rich sequence is in 
italics) was inserted into pT7-WM102 from which a small fragment had been removed 
with MscI and MluI (Figure 10). The αHL gene in pT7-WM102 contains the mutations 
Tyr-102Trp and Met-113Ala to accommodate these restriction sites. During the 
construction of pT7-WM102, a fortuitous mutation occurred, Lys-288Glu. In the pore, 
position 288 is located at the top of the cap domain (Figure 19A), in the vicinity of three 
glutamates (Glu-287, Glu-289, Glu-290). The Lys-288Glu mutation generated a shift to 
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more rapid electrophoretic mobility in the assembled pores that is of the same magnitude 
as that seen with oligo-aspartate-tailed αHL subunits (data not shown) (87). Therefore, 
the mutation allowed the separation of loop-containing αHL oligomers from each other 
and from wild-type oligomers, without additional mutagenesis or chemical modification. 
The unitary conductance of pores formed from Y102W/M113A/K288E and the specific 
hemolytic activity of the mutant on rabbit red blood cells were similar to the wild-type 
values (Figure 19B, C).  
 
 
 
Figure 19. Functional assay of WM102.  
(A) The point mutations in the WM102 αHL gene, which are proven not to interfere with the function of 
the αHL pore as seen by the ability to form a pore in bilayers (B) or on rabbit erythrocytes (C) . (B) Single 
channel recordings of triple mutant homoheptamer (WM1027)  at +100mV, in 2M KCl, 10mM MOPS, pH 
7.4.  (C) Hemolytic activity of WM102 mutant was compared with wild-type αHL (W7). Lysis of rabbit 
erythrocytes was measured by scattering of intact cells at 595 nm, which decreases upon lysis of the cells.    
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Figure 20. SDS-PAGE of monomeric Gly/Ser loop-containing αHLs. 
An autoradiograph of an SDS-polyacrylamide gel showing monomeric L subunits (L5, L15, …, L145, and 
L215) and the W subunit. Polypeptides were synthesized by coupled in vitro transcription and translation 
(IVTT) in the presence of [35S]methionine and resolved in a 10% gel without heating. The L subunits 
show decreased electrophoretic mobility that depends on the length of the loop. Preoligomerization of L5, 
and L15 is indicated with arrow and in inset. 
 
 
 
Additional loop-containing subunits were designated L(10n+5), where n is the 
number of repeat units (Figure 9). There are several different approaches for generating 
genes with repeat sequences (102, 103). In the present work, we used a type I 
endonuclease (AvaI, C∨TCGG∧G) to generate non-palindromic cohesive ends on the 
repeat units for one-step unidirectional concatemerization (88, 89) and a non-
phosphorylated cap DNA to control the average length of the concatemers (Figure 10). 
The AvaI site encodes glycine or serine, therefore only the desired amino acid sequences 
were introduced into the final constructs. Besides terminating concatemerization, the cap 
DNA provides a MluI half site. The L15 construct was used both to generate the DNA 
repeat unit for the construction of longer loops and as the recipient gene for the 
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concatemers. The recipient vector was prepared by digesting the L15 gene with AvaI and 
MluI (Figure 10). The 30 bp repeat unit was obtained by digesting the L15 gene with 
AvaI followed by preparative polyacrylamide electrophoresis. Self-ligation of the 
purified repeat unit by T4 DNA ligase in the presence of cap DNA generated the desired 
concatemers, which were gel-purified and ligated to the recipient vector. With a 1:20 
molar ratio of cap to repeat unit DNA , αHL genes with up to twenty one-tandem repeats 
were generated (Figure 10).  
 
 
 
 
 
Figure 21. Hemolysis assays of short loop-containing αHLs (0 ≤ n ≤ 2) with rabbit 
erythrocytes. 
One hour activity assays on monomeric Gly/Ser-containing subunits (L5, L15, L25) and WM102 
synthesized by IVTT. The first well in each panel contained IVTT mix (5 µL) follwed by 2-fold serial 
dilution with 50 µL in MBSA, for the next wells. For negative control 5 µL of MBSA was added to last 
row. Light scattering at 595 nm was monitored at 20ºC for 1 h.  
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The apparent molecular masses of the L subunits ranged from 33 kDa to 59 kDa 
as judged by SDS-polyacrylamide gel electrophoresis; the values are somewhat higher 
than the calculated masses (33 kDa to 49 kDa) (Figure 20). Surprisingly, the short loop-
containing mutants (0 ≤ n ≤ 2) oligomerized spontaneously after translation (arrowed, 
Figure 20), which accounted for lack of hemolytic activity (Figure 21). The inset is 
shown with a 7 d-exposure autoradiograph. Spontaneous assembly has also been noted in 
a mutant in which the transmembrane domain is deleted (14), suggesting that the kinetic 
barrier to assembly is readily lowered by tinkering with the junction of the cap and stem 
domains. However, when washed rabbit red blood cells (1%) were present during the 
translation of these short loop-containing subunits (0 ≤ n ≤ 2), slight lysis of red blood 
cells were observed in a 1 h assay. The reduced activity may partially account for low 
concentration of active heptameric forms (see below). 
 
Homooligomers Containing Short Loops Resist Limited Proteolysis and are Stable 
at High Temperatures 
To ascertain the conformational state of the oligomers, limited proteolysis was 
performed. The susceptibility of L57, L157, and L257 to proteinase K digestion was 
compared with the susceptibility of the wild-type heptamer, W7 (Figure 22).  If the 
oligomers were in a membrane-bound prepore state or a misassembled state, the amino-
latch or other regions of the polypeptide would be accessible and therefore sensitive to 
proteolysis (15, 16).  
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Figure 22. Limited proteolysis of homooligomers containing short Gly/Ser loops (0 ≤ n ≤ 
2). 
W7, L57, L157 and L257 were treated with proteinase K for 5 min at 22°C. The homooligomers were 
prepared by IVTT and assembly on rRBCM. The final concentrations of proteinase K were 0 µg/ ml (lanes 
1, 5, 9, and 13), 5 µg/ ml (lanes 2, 6, 10, and 14), 50 µg/ ml (lanes 3, 7, 11, and 15), and 500 µg/ ml (lanes 
4, 8, 12, and 16). The proteolyzed samples were resolved in either 10% (A) or 5% (B) SDS-
polyacrylamide gels without prior heating. The inset in panel B shows an autoradiograph with a longer 
exposure (21 d) of lanes 13 to 16. The two species of oligomers observed in 5% gels are designated band 
A and band B. 
 
 
 
Initially, L subunits were assembled into homooligomers by generating 
monomers with an IVTT reaction, and then oligomerizing them on rabbit red blood cell 
membranes (rRBCM). However, when the rRBCM were present during IVTT reaction, 
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the yield of oligomers was increased slightly. This might be due to the 
preoligomerization of the loop-containing αHL. For the subsequent experiments, the 
IVTT reactions were performed in the presence of rRBCM.  
Wild-type pores were stable (90% undigested) at up to 500 µg/ ml proteinase K 
as observed earlier (14, 93). However, the membrane-bound oligomers containing L 
subunits were sensitive to proteinase K treatment even at 5 µg/ ml, as visualized after 
electrophoresis in a 10% SDS-polyacrylamide gel (Figure 22A). Interestingly, the 
membrane-bound oligomers showed a more complex migration pattern in 5% gels. A 
fast migrating state (band B) was sensitive to digestion by proteinase K, while a slow 
migrating state (band A) was relatively resistant (Figure 22B). As the inserted loop 
became longer, the extent of formation of the membrane-bound SDS-resistant 
homoheptamers (band A) was reduced (as a fraction of W7 formation under the same 
conditions: L5, 31%; L15, 8%,; L25, 4%). In the case of L5, band A was resistant to 
proteinase K treatment at up to 500 µg/ ml (89% undigested). Band A from the L15 or 
L25 subunits were partly digested under the same conditions (~70% undigested).  
The fully assembled αHL pore (W7) is known to be stable in 4.3% SDS at up to 
65°C (13, 20, 29). The thermostability of the homoheptamers W7, L57, L157, and L257 
were compared by incubation at various temperatures (22°C, 47°C, 50°C, 53°C, 56°C) in 
electrophoresis sample buffer containing 4.3% SDS (92) for 5 minutes, followed by 
immediate separation in a 5% SDS-polyacrylamide gel (Figure 23). Band A was stable at 
all the temperatures tested, while band B underwent breakdown to monomers at 
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temperatures higher than 22°C.  
 
 
 
 
 
Figure 23. Thermal stability of homooligomers with short (0 ≤ n ≤ 2) Gly/Ser loops. 
Homoheptamers (W7, L57, L157, and L257) were synthesized by IVTT in the presence of rRBCM (4 
reactions, 37ºC, 1 h, 100 µL total). The washed membranes were resuspended in MBSA buffer (100 µL) 
followed by the addition of 2X Laemmli sample buffer (100 µL). The solution was then divided into five 
portions (40 µL) and incubated with a mineral oil overlay at various temperatures for 5 min. The samples 
were immediately resolved in a 5% SDS-polyacrylamide gel. Lanes 1, 6, 11, 16: 22°C; lanes 2, 7, 12, 17: 
47°C; lanes 3, 8, 13, 18: 50°C; lanes 4, 19, 14, 19: 53°C; and lanes 5, 10, 15, 20: 56°C. The inset shows an 
autoradiograph with a longer exposure (21 d) of lanes 16 through 20. 
 
 
 
L Subunits with Short Loops (n ≤ 2) Can Form Heptamers 
To determine number of L subunits in the oligomeric form, L subunits were co-
translated with W subunits at various ratios in the presence of rRBCM. The K288E 
mutation resided only in the L subunits and generated pores of increased electrophoretic 
mobility, with similar gel shifts to those observed with αHL pores containing subunits 
with four aspartate residues at the C terminus (5, 87). If there is no change of 
stoichiometry with loop insertions, heteromers with eigth different combinations would 
be observed, as illustrated in the left panel of Figure 24. For each W/L combination, we 
identified nine bands upon electrophoresis (Figure 24). As shown above, band B was 
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sensitive to digestion by proteinase K and was unstable above room temperature (Figure 
22, 23). Further, the protein in band B failed to form pores in planar lipid bilayers and 
may comprise misfolded and/or misassembled pores. Therefore, band B was not 
investigated further and not counted as a distinct subunit combination. Band A was 
separated into a ladder of eight species, each stepwise shift in electrophoretic mobility 
corresponding to the incorporation of one L subunit into the αHL oligomer (5, 87, 93). 
The results indicate that the homooligomers formed by L5, L15 and L25 are indeed 
heptamers and that all possible combinations of W and L subunits can associate.  
In a control experiment, heteromers formed from W subunits and subunits 
obtained by IVTT of pT7-WM102 (containing the gene for Y102W/M113A/K288E with 
no encoded loop) were resolved in a 5% gel. Eight bands were again observed, in this 
case without a band B species (data not shown). The band A components for L5, L15 and 
L25 (the presumed homoheptamers) co-migrated with homoheptamers of the pT7-
WM102 protein.  
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Figure 24. Assembly of heteromeric αHL pores with short Gly/Ser loop-containing 
subunits (0 ≤ n ≤ 2). 
Separation by SDS-polyacrylamide gel electrophoresis of heteromers formed from the W subunit and L 
subunits (L5, L15, and L25). L5, L15, and L25 DNA templates were mixed with wild-type DNA template 
(W) in the ratios indicated above the lanes and the washed membranes were solubilized in MBSA buffer 
(40 µL), mixed with an equal volume of 2X Laemmli sample buffer and subjected to electrophoresis 
without heating. The autoradiogram shows the electrophoretic ladders generated by the K288E mutation in 
the L subunits. The magnitude of the shift towards greater mobility depends on the number of L subunits 
in an oligomer. The black dots show the eight bands, indicative of a heptamer, that were formed in 
addition to band B. The inset shows an autoradiogram with a longer exposure (21 d) of the boxed region. 
Graphic representation of the heteromers are shown in the left panel corresponding to the species resolved 
in gel. All possible permutations of L subunit and W subunits are illustrated. The various permutations of 
each combination are not separated.  
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Figure 25. Thermal stability of heteromers with short Gly/Ser loops (0 ≤ n ≤ 2) in the 
lumen. 
Heteroheptamers (L5/W, L15/W, and L25/W) were obtained by co-translation (37ºC, 1 h) from the W and 
L subunit DNA templates (L5, L15, or L25) in various ratios (W to L = 4: 0, 3: 1, 1: 1, 1: 3, 0: 4) in the 
presence of rRBCM. The oligomers obtained at the different ratios were pooled and treated at various 
temperatures as described in Figure 23. Lanes 1, 6, 11, 16: 22°C; lanes 2, 7, 12, 17: 56°C; lanes 3, 8, 13, 
18: 59°C; lanes 4, 19, 14, 19: 62°C; lanes 5, 10, 15, 20: 65°C. 
 
 
 
Heterooligomers Containing Short Loops Are Stable at High Temperatures 
Heteromers made with wild-type subunits and loop-containing subunits (L5/W, 
L15/W, and L25/W) showed similar stability regardless of the length of the inserted loop 
(Figure 25). By contrast, the number of loops in a pore did affect its stability: heteromers 
with six L subunits (L(10n+5)6W1 n = 0, 1, 2) were stable at up to ~60°C, heteromers 
with three to five L subunits (L(10n+5)3 to 5W4 to 2 n = 0, 1, 2) were stable at up to ~63°C, 
while L(10n+5)1W6,  and L(10n+5)2W5, (n = 0, 1, 2) were as stable as the W7 pore. 
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Figure 26. Maximum allowed number of L subunits in the heteroheptameric pores.  
(A) Heteroheptamers (L5/W, L15/W, …, L145/W, L215/W) were synthesized by IVTT in the presence of 
rRBCM for 1 h at 37ºC. The templates were mixtures of W subunit DNA and L subunit DNA in a 1: 1 
ratio. Membrane-bound oligomers were resolved in 5% SDS-polyacrylamide gels without prior heating. 
(B) Heteromers formed from the K288E revertants (L105K/W, L145K/W, L215K/W) were generated by 
co-translation in the presence of rRBCM and resolved in a 5% gel without prior heating. The templates 
were mixtures of W subunit DNA and L(10n+5)K subunit DNA in a 1: 1 ratio. 
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Figure 27. Limited proteolysis of heteromeric αHL pore with one long loop of 105 
residues. 
W7, and heteromers of L105 and W subunits (L105/W) were treated with proteinase K for 5 min at 22°C. 
The oligomers were prepared by IVTT and assembled on rRBCM. The final concentrations of proteinase 
K were 0 µg/ ml (lanes 1, and 5), 5 µg/ ml (lanes 2, and 6), 50 µg/ ml (lanes 3, and 7), and 500 µg/ ml 
(lanes 4, and 8). The proteolyzed samples were resolved in a 5% SDS-polyacrylamide gel without prior 
heating. The protease resistant heteromer L1051W6 is shown (arrow).  
 
 
 
Subunits Containing Longer Loops Form Heteroheptamers with Wild-Type αHL 
Subunits, but Not Homoheptamers 
To explore the capacity of the cavity in the αHL pore for L subunits with longer 
loops (n ≥ 3), additional heteromers were assembled with W subunits (Figure 26). For 
short loops (0 ≤ n ≤ 2), pores with seven L subunits could form (Figure 24). However, if 
the loops were longer than 25 residues (n ≥ 3), the L subunits could not assemble by 
themselves (data not shown), but they did form heteromers with W subunits (Figure 26). 
Four subunits of L35 (n = 3) were able to assemble with three W subunits, while up to 
three subunits of L45 (n = 4) were incorporated into heptamers. For longer loops (n = 5 
or 6), up to two L subunits were tolerated. For loops with more than seven repeats (7 ≤ n 
≤ 10, n = 14 or 21), only one L subunit was incorporated. The L105/W heteromers (67 % 
at 500 µg/ml proteinase K treatment) were proteinase-resistant (Figure 27). When higher 
ratios of L: W were tested (up to 6 to 1), no additional L subunits were incorporated. 
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Longer exposure (21 d) of the dried gels to X-ray films failed to demonstrate the 
incorporation of  additional L subunits. 
The electrophoretic mobility of the L1W6 heptamers was reduced when the length 
of the loop was longer than 95 residues. In these cases, the effect of the loop on 
electrophoretic mobility outweighed that of the K288E mutation. For example, L1051W6 
migrated slightly more slowly than L1W6 for L5 through L95, while L2151W6 migrated 
more slowly than even W7 (Figure 24). When the K288E mutation was reversed (to 
“E288K”), the ladders caused by the incorporation of L subunits were not observed, but 
the decrease in electrophoretic mobility caused by the insertions in L1451W6 and 
L2151W6 were clearly visible (Figure 26B), suggesting that the additional polypeptide 
chain protrudes out of the lumen. This assumption was further substantiated by the 
electrical behavior of pores in bilayer experiments (see below). 
 
Single-Channel Recordings of Loop-Containing Pores 
The properties of gel-purified loop-containing oligomers were examined by 
planar bilayer recording in 2 M KCl, 10 mM MOPS, pH 7.4 (Figure 28). Unitary 
conductance values for L57 and L157 were 1.91 ± 0.02 nS (N = 4) and 1.90 ± 0.02 nS (N 
= 3), respectively, at +100 mV. Under the same conditions, the unitary conductance of 
W7 was 2.18 ± 0.21 nS (N = 7). Like W7, the currents were devoid of substates. By 
contrast, when the cavity was fully packed with polypeptide loops, the residual current 
was greatly reduced relative to W7: L354W3, 1.10 ± 0.04 nS (N = 3); L256W1 , 1.01 ± 
0.15 nS (N = 4); L257, 0.67 ± 0.02 nS (N = 5) (Figure 28).  
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Figure 28. Single-channel recordings of αHL pores containing Gly/Ser loops. 
(A) Single-channel recordings were performed at +100mV in 2 M KCl, 10 mM MOPS, pH 7.4. The 
currents were filtered at 10 kHz. Each heteromer was obtained by IVTT (37ºC, 1 h) in the presence of 
rRBCM and purified from a preparative 5% gel. (B) The single-channel current values were determined 
and expressed as a percentage of the W7 current. Error bars indicate standard deviations of the mean (N = 
8 for W7, N = 3 to 5 for the rest). The recording conditions are same as in (A). The total number of 
inserted amino acids in the examined pore increases along the x-axis, except for L1451W6 and L2151W6, in 
which a portion of the loop is presumed to be outside the lumen. 
 
 69
With a single long loop (n = 8 or 10), transient partial closures of the pore were 
observed at positive applied potentials, but not at negative potentials (Figure 29). The 
closures are similar to those seen with αHL pores with PEG chains covalently attached 
within the cavity (8). The lifetimes of the closures were 99 ± 7 µs for L851W6 and 593 ± 
63 µs for L1051W6. The unitary conductance values were 1.59 ± 0.01 nS and 1.72 ± 0.08 
nS, respectively, for L851W6 and L1051W6 and the amplitude of the blockade in the 
closed state was ~1.53 nS in both cases. Unlike L851W6 and L1051W6, L1451W6 and 
L2151W6, the pores with the longest loops, exhibited high unitary conductance values 
and no closures at both positive and negative applied potentials. Hence, they were 
similar to W7, L57 and L157. The conductance values were: L1451W6, 2.06 ± 0.11 nS (N 
= 4) and L2151W6, 1.92 ± 0.04 nS (N = 4). Again, this observation suggests that a 
inserted long loop ( n=14 or 21) resides mainly outside the pore, and does not affect the 
overall current flow (no blockade, no reduction of conductance). 
 
Summary 
Here, an unusual piece of protein engineering is described, in which an internal 
cavity within a transmembrane protein pore has been filled with additional polypeptide 
sequences. The engineered heptameric pores contain either seven short polypeptide loops 
(0 ≤ n ≤ 2) or a smaller number of long loops (3 ≤ n ≤ 21). The pores are stable as judged 
by protease-sensitivity and thermolability, and functional as judged by their ability to 
form pores in planar lipid bilayers.  
 
 70
 
 
Figure 29. Single-channel recordings of long loop-containing αHL pores at negative 
potentials.  
Electrical current of W7, L851W6 and L1051W6 pores were measured at –100 mV, in 2 M KCl, 10 mM 
MOPS, pH 7.4.   
 
 
 
L257 was the homomeric pore that contained the largest amount of foreign 
sequence: 175 residues. The electrophoretic mobility of L257 (E288K reverted) was 
identical to that of W7, suggesting that its hydrodynamic properties are unaltered and 
therefore that the additional polypeptide chains are contained within the protein. The 
conductance of L257 was 31% of that of W7; therefore hydrated ions are still free to pass 
through it (Figure 28). The current passing through the pore exhibited excess noise, 
which might arise from movement of the loops near the constriction or from 
destabilization of the structure (Figure 28). 
The accessible volume of the cavity in the cap domain is 32,600 Å3, as calculated 
by the slice of the enclosed central cavity, which divides the volume by seven (Figure 
17). The pore that contained the most foreign residues, 175, was L257. To estimate the 
accessible volume take by the L25 loops, molecular graphic model of a L25 loop was 
generated by Swiss-Model. By rolling a probe, whose radius is 1.4, along the molecular 
surface of the L25 loop, the accessible volume taken up by a L25 loop was 8,330 Å3, 
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which generated the total volume of seven L25 loops were 23,200 Å3. Therefore, they 
must remain highly hydrated within the cavity, in agreement with the ability of the L257 
pore to conduct ions, based on single-channel recordings. Furthermore, since there are no 
interaction with each other, the total volume taken up by the loop would be larger than 
the estimated accessible volume deduced from the L25 loop model.  
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Figure 30. Accessible surface volumes of proteins from protein data bank. 
Solvent accessible volumes of twenty two sample proteins were plotted against the number of residues. 
These proteins are globular, monomeric proteins with 100-300 residues, defined by X-ray analysis at 2.7A 
resolution or better (1CHH, 1A2P, 2PYP, 132L, 1A29, 1A2T, 1D1M, 1F18, 142L, 1CV8, 1AHN, 1FAJ, 
1WBA, 1BG7, 1KHI, 1L4U, 1JUV, 1ATK, 1AQ7, 1C4F, 1AG1, 1DUI). The data were fitted to a straight 
line, to determine the corresponding number of residues for 32,600 Å3 accessible surface volume. 
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The accessible volumes of twenty two proteins (1CHH, 1A2P, 2PYP, 132L, 
1A29, 1A2T, 1D1M, 1F18, 142L, 1CV8, 1AHN, 1FAJ, 1WBA, 1BG7, 1KHI, 1L4U, 
1JUV, 1ATK, 1AQ7, 1C4F, 1AG1, 1DUI) containing 108 to 275 residues were 
determined by SPOCK and then plotted versus the number of residues. From a linear fit, 
the number of residues corresponding to an accessible volume of 32,600 Å3 is 176 
(Figure 30). With these results, we can speculate that the cavity of the αHL pore could 
be packed with a folded protein with ~175 residues. Given the consideration of surface 
charges and the shape of a protein, the actual maximum limit would be less than 175 
residues. An attempt to place a folded protein (98 residues plus 17 residues of linkers) in 
the αHL central cavity is currently investigate. 
Only one copy of the largest loops (more than 75 amino acids) could be 
incorporated per heptamer, which is reminiscent of attempts to place covalently-attached 
PEG chains within the pore (8). For example, only one copy of a 5-kDa PEG could be 
placed within the cap domain. Pores with more than one PEG chain failed to assemble. 
The unitary conductance of pores of the form L1W6 did not differ greatly from W7. For 
example, the conductance of L1051W6 was 79% of W7. Interestingly, L1051W6 and 
similar pores (n = 8 to 10), exhibited transient closures (Figure 28A), suggesting that the 
loop was able to move into the constriction and almost completely block the pore. When 
the loop was larger still (n = 14 and 21), no closures were seen (L1451W6 and L2151W6, 
Figure 28A), suggesting that in these cases the loop is extruded through the cis entrance 
into the medium in keeping with the altered electrophoretic mobility of these pores. In 
the cases of L1451W6 and L2151W6, but not L1051W6, the electrophoretic mobility was 
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significantly reduced compared to W7 (Figure 26B).  
 
 
Table 7. Single-channel current recordings of a Gly/Ser loop-containing αHL pores. 
αHL pore Molecular weight of polymer (kDa) 
Closed event 
duration (µs) 
Closed event 
frequency (s-1) 
L651W6 4.7 65 ± 7  155 ± 129 
L851W6 6.1 269 ± 50 122 ± 7 
L1051W6 7.5 593 ± 63 85 ± 5 
αHL-PEG-3K* 3.0 132 ± 10 26 ± 10 
αHL-PEG-5K* 5.0 13700 ± 2200 0.20 ± 0.02 
The values are the mean ±  SD for at reast five single-channel recordings. 
*The electrical signatures of PEG-tethered αHL pores were adapted from the work by Movileanu et al. (7).  
 
 
 
This finding is again reminiscent of the properties of pores containing covalently-
attached PEG chains (7,8). For example, a pore containing a 3.4 kDa chain, terminated at 
the free end with biotin, comigrated with unmodified heptamer (W7) and exhibited 
numerous spikes towards lower conductance, like L1051W6. When the PEG chain was 
captured in the cis compartment with streptavidin, the current became quiet, like that of 
L2151W6, suggesting that a portion of L2151W6 loop is protruding out of the lumen. 
Furthermore, the electrical signature of the modified αHL pore with a polymer (Gly/Ser 
loop or PEG) showed similar results (Table 7). As the length of the attached polymer 
lengthened, the dwell time of the events increased, while their frequency reduced. 
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CHAPTER IV 
INTRODUCTION OF A TEMPERATURE-RESPONSIVE GATING 
MECHANISM INTO THE ALPHA-HEMOLYSIN PORE 
 
Molecular Design of the αHL Subunit Containing an ELP Insertion 
Based on the work in previous chapter, three different lengths of elastin-like 
polypeptide repeats (ELP repeats, (ELP=(VPGGG)n, where n is 5, 10, and 20) were 
inserted before αHL residue S106 by cassette mutagenesis. It has previously been shown 
that the modification at S106 of αHL does not interfere with the protein assembly (8). 
We designed ELP loops of 5, 10, and 20 tandem repeats of the VPGGG pentapeptide, 
plus one valine (as a result of cloning) and ten residues of Gly/Ser linker sequences. The 
resulting αHL constructs containing these inserts (E) are E5, E10, and E20, respectively, 
which contain 36, 61, and 111 amino acid residues (Figure 31).  
The given sequence of ELP at salt concentration was anticipated to have a 
transition temperature (Tt) at ~35ºC where single channel measurements are performed 
(1 - 2 M NaCl), according to extensive studies by Urry’s group (32). However, the 
bulkiness or hydrophobicity of the inserted ELP residues could interfere with the folding 
of water-soluble αHL. Furthermore, the insert might interfere with the assembly process, 
especially the prepore to pore transition (6, 20). To facilitate the detection and analysis 
of the temperature effect on the αHL pore, it would be better to have the current 
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fluctuation (i.e. close and open states) with engineered ELP containg αHL pore. From 
the initial work with Gly/Ser loop-containing αHL pores (chapter III), the length 
dependence of the electrical current fluctuation and the number of L subunits in the 
heptamer were observed. Three different lengths (36, 61, 111 residues) of ELP loop 
were selected, which were generating partially closed states with the Gly/Ser-loop 
containing αHL pores with similar loop length (35, 65, 105 residues).  
 
 
Figure 31. Diagram of ELP-containing αHL genes. 
Concatamerized ELP repeat unit with flanking glycine-serine linkers were inserted by cassette 
mutagenesis between N105 and S106 in a wild-type αHL subunit with a polyaspartate tail (WD). The 
ELP-containing subunits were denoted as E5, E10, and E20, where the number represents the total 
number of inserted VPGGG repeats.  Each repeat unit consists of five tandem repeats of VPGGG. 
 
 
 
Instead of cloning an ELP repeat encoding one VPGGG motif, a tandem penta-
repeat of VPGGG was cloned into the pYH1-αHL D4 vector (Table 3) using NdeI and 
HindIII sites, to facilitate concatemer formation of the desired length (Figure 11). By 
comparison, the earlier Gly/Ser repeat unit was composed of the 10 residues 
(SGSGSGGSGS). To produce a concatemer with ten tandem repeats of SGSGSGGSGS, 
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many trials were attempted. Not only was the yield of concatemers with a high number 
of repeats low, but the resolution of purification gel was poor since there is only a 30bp 
difference between neighboring concatemers. Here, by designing a longer the repeat unit 
(75 bp, (VPGGG)5), both yield and resolution of higher concatemers were improved.  
The repeat units from the pYH1-EM D4 vector were purified after digestion with 
EarI, which is a type II endonuclease. Type II enzymes digest DNA at sites outside the 
recognition sequences. Therefore the repeat unit would code only the ELP sequences 
without insertion of any unnecessary sequences. The 5’ ends of purified repeat units 
were phosphorylated to facilitate head-to-tail ligation. Due to EarI cohesive ends, one 
additional residue of valine was added to the C-terminus of each ELP repeat, giving the 
final ELP sequence as (VPGGG)5nV, where n is 1, 2 or 4. Each concatemer was flanked 
with 5 residues of flexible Gly/Ser linker sequences (Figure 31) to minimze any 
structural perturbation to main body of αHL. Purified concatemers of the desired length 
(5, 10, 20 repeats of VPGGG) were cloned into the recipient vector (pYH1-EC D4) 
using EarI and MluI sites, to generate the ELP-containing αHL genes (E5, E10, and 
E20) (Figure 12).  
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Figure 32. SDS-PAGE of monomeric E subunits with different lengths of a ELP loop 
An autoradiogram of an SDS-polyacrylamide gel is shown for monomeric ELP containing subunits (E5, 
E10, E20) and the monomeric W subunit. Polypeptides were synthesized by coupled in vitro transcription 
and translation (IVTT) in the presence of [35S]methionine and resolved in a 10% gel. 
 
 
 
Generation of Heteromeric ELP-containing αHL Pore 
The molecular masses of the subunits E5, E10, and E20 were approximately 35 
kDa, 37 kDa and 45 kDa, respectively, as determined by SDS-PAGE, which is in good 
accordance with the calculated molecular masses (36.4 kDa, 38.2 kDa, and 41.9 kDa for 
E5, E10 and E20, respectively) (Figure 32). Heteroheptamers of W and E subunits were 
prepared by in vitro transcription and translation (IVTT) in the presence of purified 
rabbit red blood cell membranes (29). The templates were 1:1 molar ratio mixtures of 
plasmids encoding W subunit and E subunit, which generated the best resolution for all 
the possible heteromers. No additional incorporation of E subunits to a heptamer were 
detected even at higher W/E template molar ratio (data not shown). As fully assembled 
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heptamers are known to be stable in SDS if not heated (6), washed membrane bound 
heptamers were resolved in SDS-PAGE without heating (Figure 33). 
 
 
 
Figure 33. Heteromers by E subunits with different length of inserted ELP. 
An autoradiograph shows electrophoretic shifts generated by polyaspartate tail (D4) on C-terminus of E 
subunits. The dotted bands (red for W7 and black for E1W6 heteromers) were excised from a preparative 
gel for single-channel recordings.  
 
 
 
Heteromers with E and W subunits showed downward electrophoretic shifts 
according to the number of subunits with oligoaspartate tail (D4) (Figure 33). Up to five 
E5 subunits were tolerated in E5/W heteromers, whereas only four L35 subunits were 
tolerated in L35/W heteromers (Figure 26). These findings might account for less 
probability to confine more flexible Gly/Ser- loops in the cavity than ELP-loops during 
oligomerization. Interestingly, we found different electrophoretic migration patterns for 
large ELP-inserted loop (E201W6, dotted), which were similar to pores with a long 
 
 79
Gly/Ser loop insertion (L1451W6 and L2151W6, Figure 26), but in reverse direction 
(slower migration). The L1451W6 and L2151W6  exhibited slower migration while 
E201W6 showed faster migration in 5% gel. Since there are no extra charged residues in 
the ELP loop, we can assume that the disposition of the loops contributes to the 
additional shifts, as observed previously with PEG-modified αHL pores (8). Heteromers 
with one loop (E(5n)1W6 (n=1, 2,4) or (Ln)1W6 (n=35, 65, 115, chapter III), were 
purified from polyacrylamide gels and subjected to a  second SDS-PAGE analysis after 
heating to disassemble heptamer into monomers. The relative intensity reading of E 
subunit to W subunits were approximately 1:6 for three different trials (E51W6; 1:6.3 ± 
0.8 (N=3), E101W6; 1:5.8 ± 0.48 (N=3), E201W6; 1:6.5 ± 0.7 (N=3)). These heteromers 
were further studied with single-channel electrical recordings.  
 
Insert Length-dependent Electrical Behaviors 
Currents flowing through individual αHL pores were recorded at +80 mV in 2 M 
KCl, 10 mM potassium phosphate, pH7.5 (Figure 34). These conditions were chosen to 
maximize the signal to noise ratio over a wide temperature range. At room temperature 
(23 ± 0.5 °C), the current flowing through a single wild-type αHL pore (W7) was 164 ± 
6 pA (N=7). Advantageously for this study, W7 pore remained opened for an indefinite 
period of time even at elevated temperatures. The open-state current amplitude through 
individual ELP-containing αHL pores (E1W6) were significantly reduced and decorated 
by transient short-lived current blockade events (closed states). 
As the inserted loop was lengthened, the amplitudes of both the open state and 
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the closed state were reduced (Figure 34B-D). For heteromers with one short ELP loop 
(E51W6, Mw=2.6 kDa, 36 amino acids), we observed an open-state current of 139 ± 8 pA 
(N=4), which is a 15.2 ± 2.5 % reduction (Figure 34B) comparing to the open-state of 
the W7 pore. The very short-lived negative spikes are characterized by a duration, 
current amplitude and frequency of 108 ± 12 µs (N=4), 98 ± 11 pA (70.5 % of open 
state, n=4) and 140 ± 9 s-1 (N=4), respectively. Similar results were observed when a 
flexible poly(ethylene glycol) (PEG-3 kDa) chain was covalently attached through a 
disulfide bond to S106C of an αHL subunit (7, 8). The duration and frequency were 130 
± 10 µs and 26 ± 10 s-1, for single PEG-3 kDa modified αHL pore assayed in 300 mM 
KCl, 5 mM Tris-HCl (pH 7.0), 100 µM EDTA.  The short-lived negative spikes were 
interpreted as excursions of the peptide loop across the constriction of the αHL pore.   
For heteromeric pores with a medium-sized ELP loop (E101W6), the open-state 
current amplitude is further reduced to 123 ± 5 pA (N=14). The transient current 
blockades were also augmented (95 ± 2 % of open state, N=14), less frequent (61 ± 7 s-1, 
N=14) and of longer duration (2.6 ± 0.28 ms, N=14) (Figure 34C). This result was 
anticipated; in the limited volume of the cavity, a longer loop is expected to be less 
mobile than a shorter loop, as the volume occupied by the hydrated longer ELP loop 
would be larger than the shorter one. Similar length dependent current behavior was 
observed with single PEG-5 kDa chain modified αHL pores (7). The duration (13.7 ± 
2.2 ms) was lengthened and the frequency (0.20 ± 0.02 s-1) was reduced compared to the 
PEG-3 kDa modified αHL pores.  
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In case of a long ELP-loop-containing αHL pore (E201W6), a substantial 
reduction in the open-state current amplitude (104 ± 5 pA (N=3) ) was observed (Figure 
32D), which was accompanied by full current blockades (99 ± 1 %, N=3) of long 
duration (45.0 ± 5.3 ms, N=3) and lowered frequency (19 ± 2.7 s-1, N=3) (Table 8). 
Substantially increased noise levels observed at both the open and closed states might 
account for the movement of the loops near the constriction or for the destabilization of 
αHL pore.    
 
Table 8: Single-channel electrical signatures of ELP-containing αHL pores. 
αHL 
pore 
No. of 
residues 
in loop 
Molecular 
mass of 
loop 
(kDa) 
Ic/Io* 
Closed event 
frequency (s-1)
Closed event 
duration (µs) 
E51W6 36 2.6 
0.29 ± 0.4 
(4) 140 ± 9 (4) 108 ± 12 (4) 
E101W6 61 4.4 
0.05 ± 
0.02 (14) 61 ± 7 (14) 2600 ± 280 (14) 
E201W6 111 8.1 
0.01 ± 
0.01 (3) 19.0 ± 2.7 (3) 45000 ± 5300 (3)
L651W6 65 4.7 
0.14 ± 
0.03 (3) 155 ± 12 (3) 65 ± 7 (3) 
The values are the mean ± SD for at least three distinct single-channel experiments. 
*Ic/Io is the normalized amplitude of the closed state by the amplitude of  the open-state. 
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Figure 34. Effect of ELP loop length on currents of αHL pores. 
Single channel recordings of W7 (A), E51W6 (B), E101W6 (C), and E201W6 (D) were analyzed at room 
temperature (23 ± 0.5ºC) in 2 M KCl, 10 mM K-phosphate buffer, pH 7.5. The transmembrane potential 
was +80 mV. The recorded current was low-pass 8-pole Bessel filter 20 kHz and sampled at 50 kHz. The 
right hand panels are representative the traces for each pore and the left hand panels are the all-point 
histograms corresponding to the single-channel recordings. Note that as the loop lengthens the currents of 
open and closed states are reduced and the duration of the closed states lengthened. 
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Figure 35. Single-channel recordings of the E101W6 pore at different temperatures. 
The electrical current through the E101W6 pores were studied at 20ºC (A), 40ºC (B), and 60ºC (C). The 
holding potential was +80 mV. The temperature was controlled by connected PC, through an external 
command connection via Digidata 1322A, which converts the analog data to the digital data. The current 
and the temperature were simultaneously monitored by the Clampex 9.2 software. Other experimental 
conditions are the same as those presented in Figure 34. 
 
 
 
Table 9: Single-channel electrical signatures of E101W6 pores at different temperatures. 
Temperature 
(ºC) P1 P2 
Duration of short 
occupied states (µs) 
Duration of long 
occupied states (µs) 
Total event duration 
(µs) 
20 0.05 ± 0.02 
0.95 ± 
0.02 390 ± 36  4200 ± 240  4000 ± 380 
40 0.67 ± 0.03 
0.33 ± 
0.03 231 ± 27  1800 ± 160 750 ± 91 
60 0.95 ± 0.02 
0.05 ± 
0.02 120 ± 16 720 ± 83 150 ± 21 
The values are the mean ±  SD for at reast five single-channel recordings. 
P1 and P2 are the probability of the short and long occupied states, respectively. 
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Electrical Recordings of an ELP-containing αHL Pore at Different Temperatures  
The heteromer, E101W6, was further studied with single-channel recordings to 
seek evidence for  temperature-dependent gating mechanisms. With the other ELP loops, 
the electrical signals were either too short to resolve or too infrequent to analyse. E51W6 
produced very short-lived transient events at room temperature, with an average duration 
of 108 µs (Figure 34B, Table 8), but the individual current blockade events were hardly 
resolvable at elevated temperatures (data not shown). The main state of the E201W6 pore 
was the closed state with probability of 0.80 ± 0.06 (N=3) at room temperature, which 
required longer recording time to obtain the significant data. However, E101W6 
produced full current blockade events at 20°C, and the signals were resolvable 
throughout the temperature range examined in this work (20 – 60°C) (Figure 35).  
The characteristics of both the open-state current amplitude and individual 
current blockade events are highly temperature-sensitive. First, the open-state current 
amplitude of the E101W6 pore increases with temperature from 119 ± 7 pA (N=8) at 20 
°C to 189 ± 11 (N=5) and 301 ± 12 pA (N=5) at 40 and 60 °C, respectively (Figure 35), 
as expected due to the increase in conductivity of the bulk solution. There were two 
types of closing events, one of short duration and another of long duration. For example, 
at 20 °C, we observed complete transient blockades with a duration of 390 ± 36 µs (the 
probability P1=0.05 ± 0.02, the short occupied states) and 4.20 ± 0.24 ms (P2=0.95 ± 
0.02, the long occupied states) (N=8). The total event frequency recorded at this 
temperature was 43.0 ± 5.7 s-1. The total event frequency of events (both short and long 
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occupied states) increased substantially with the temperature while the duration of the 
events were reduced. At 40ºC and 60ºC, the total closed state event frequencies were 
165 ± 17 s-1 and 475 ± 38 s-1, respectively. The duration of events was 750 ± 91 µs 
(N=5) and 150 ± 21 µs (N=5) at 40 °C and 60 °C, respectively (Table 9).  
 
 
Figure 36. Single channel recordings of a Gly/Ser loop-containing αHL pore (L651W6) 
at different temperatures. 
As the L651W6 pore accommodates a similar number of exogenous amino acid residues in the central 
cavity of the αHL pore as E101W6, single channel recordings were conducted at 20ºC (A), 40ºC (B), and 
60ºC (C), for comparison with the E101W6 pore (Figure 35) at same temperatures. All the conditions for 
the recording and analysis are same as in Figure 33. 
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To verify the identity of the temperature-dependent responses of E101W6, we 
carried out single-channel electrical recordings for a pore with Gly/Ser loop (L651W6) of 
closely similar length (Figure 36) in similar conditions to those presented in Figure 33. 
Gly/Ser loop sequence is expected not to follow an inverse structural transition as the 
temperature increases, since the ELP sequence and the abductin sequence are known to 
be the only polypeptides that exhibit temperature-dependent inverse transitions. At 
20°C, the single-channel electrical recordings of L651W6 pore revealed very short-lived 
negative current spikes (65 ± 7 µs, N=3). At 20°C, the open-state current amplitude of 
L651W6 was 135 ± 7 pA (N=3), while the closed state amplitude was only 17 ± 11 pA 
(N=3) (Figure 34A). At 60 °C, the open-state and closed state amplitudes were 336 ± 12 
pA (N=3) and 50 ± 12 pA (N=3) (Figure 36C). The event duration was very short 
compared to that of E101W6 pore, under the same conditions (Figure 35), suggesting the 
Gly/Ser loop is more flexible than the ELP loop in the cavity. 
Due to the increase of the bulk solution conductivity with the temperature (104), 
the amplitude of the currents through L651W6 and E101W6 were observed for both the 
open and closed states (Figure 37). To cancel out the effect of solution conductivity, the 
amplitude of the closed state current was normalized by that of the open state current 
and then plotted against temperature (Figure 37B). When the data points were fitted with 
sigmoidal curve, E101W6 showed two-state transitions with the mid point located at 38.1 
± 0.4 °C (N=5), while the L651W6 did not show any changes with temperature. With 
extensive study by Urry’s group(32, 38, 40), this transition temperature was estimated as 
~ 32°C with VPGGG repeat. 
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Figure 37. Temperature-dependent conductance of the αHL pores. 
(A) The conductance of αHL pores, W7, L651W6, and E101W6 were measured at +80 mV in 10 mM K-
phosphate buffer, 2 M KCl, pH 7.5 at different temperatures. The net conductivity of the solution is 
increasing with the increase of temperature. Filled square (■) is for W7 pore, open circle  (○)L651W6 pore; 
and filled triangle (▲) E101W6 pore. (B) The closed state current of E101W6 (black) or L651W6 (red) was 
divided by the open state current of the corresponding pore to cancel out the bulk solution effect and 
plotted against temperature. All the data measured at +80 mV and repeated at least with five distinctive 
single-channel recordings.  All point were fitted with sigmoidal curve.  
 
 
 
A simple model with four states, which illustrates the temperature-induced 
changes in the open-state and the closed state, is presented in Figure. 38.  States I and II 
represent the open and closed states, respectively, of the ELP-containing αHL pore at 
temperature below Tt. States III and IV indicate the open and closed states, respectively, 
of the ELP-inserted αHL pore at temperature above Tt. The transition between the I and 
II states to the III and IV states requires energy, in this case heat. Therefore at given 
temperature, only the state with low residual current (states I and II) or the state with 
high residual current (state III and IV) was observed. 
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Figure 38. Model of temperature-responsive gating mechanism for an ELP-containing 
αHL pore. 
The low conductance states account for the state of inserted ELP in the lumen at below the transition 
temperature (I and II states). The high conductance states account by the hydrophobic collapsed ELP 
insert in the lumen at above Tt (III and IV states). At positive potentials, some parts of the loop may be 
jammed in the constriction region, which is responsive for closed states (II and IV states). At above Tt, the 
ELP portion is more compactly packed than the state below Tt. The rigidity and the reduced volume of the 
ELP accounts for shorter blockade duration at above Tt.  
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Summary 
Staphylococcal αHL pores was engineered to exhibit a temperature-responsive 
gating mechanism. Controlled number of ELP repeats with defined length were located 
in the central cavity of the αHL pore. The amplitude and the frequency of the transient 
blockades increased as the temperature increased from 20ºC to 60ºC, while their 
duration decreased. When the amplitude of blockade was normalized with that of the 
fully open state, a sigmoidal two-state transition was found, with the midpoint at 38.1 ± 
0.4ºC. As the estimated transition temperature for VPGGG repeat was ~ 32ºC , 
according to Urry, this observation was proposed as the result of the ELP inverse 
transition. Different guest residue in the ELP sequence, which changes the transition 
temperature would provide further evidence fot the identity of the temperature-
dependent behavior of the engineered αHL pore. In the future, ELP sequences within 
αHL pores might be engineered further to allow, for example, the temperature-
controlled release of drugs from lipid vesicles or the permeabilization of mammalian 
cells for the introduction of cryoprotectants.  
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CHAPTER V 
PROTEIN ANALYTES DETECTED WITH AN αHL PORE 
 
Generation of an αHL with an Encoded PKI Loop  
Based on the work with the Gly/Ser loop- containing αHL pores, a loop length of 
115 residues was determined to be a candidate for PKI fragment 
(TTYADFIASGRTGRRNAIHD, 5-24 residues) insertion at near the mid region of the 
loop. From electrophoretic migration assays and single-channel recordings with long 
Gly/Ser loop containing αHL pores, (L1051W6, L1451W6, and L2151W6), the minimal 
length of an inserted loop that will protude out of the lumen is ~ 105 residues. Also 
conformational changes of 20 residues of PKI fragment (5-24) was observed when it is 
bound to the PKA catalytic subunit, indicating some extra residues might be needed to 
ease the interaction. Therefore a 115 residue-long loop would serve as the adequate 
length to make the loop move in and out of the lumen without any struggle and for the 
PKI fragment to interact with the PKA catalytic subunits.  
Initially, the pYH2-L105 D4 and pYH2-L45 D4 constructs were generated to 
place single cysteine residue at the mid point of the Gly/Ser loop. By modifying the 
cysteine with commercially available iodoacetyl biotin (biotinyl-iodoacetamidyl-3,6-
dioxaoctanediamine, Pierce, Rockford IL), an attempt to evaluate the topology of a 
Gly/Ser loop (105 residues and 215 residues) and/or the frequency of its availability at 
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outside of the lumen (mainly at cis side) were tried. This iodoacetyl biotin has shortest 
spacer arm (polyethylene oxide, 24.7Å) in commercially available cysteine-specific 
biotins. The electrical traces of biotin tethered αHL pores were decorated with 6 extra 
substates (data not shown). These result might account for the the fast transitions of the 
polymer due to the flexibility of the spacer arm. Furthermore, addition of wild-type 
streptavidin to the cis side of the chamber failed to show changes in any of 6 substates, 
indicating the distance of the biotin probe might be too far away from the cis mouth of 
the pore. Due to the complexity of the signals, this constructs were not further studied.  
Four strands of single strand DNA,  encoding SSGSTTYADFIASGRTGRRNA-
IHDGSGSGSS (PKI fragment (5-24) and Gly/Ser linker sequences (italic)), were ligated 
between SacI and XhoI sites of the PCR fragments, which represents N-terminal (light 
blue) and C-terminal (red) halves of the αHL gene (Figure 14). The PKI fragment was 
placed near the mid point of the PKI 115 loop (115 residue-long loop with PKI 
fragment) as intended, while it was shifted towards N-terminus during cloning for PKI 
206 loop (206 residue-long loop with PKI fragment) (Figure 39). The αHL subunit with 
PKI sequence is denoted as Pn subunit, where n is for the number of exogenous loop 
residues (115 or 206) (Figure 39).  
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Figure 39. Diagram of protein kinase inhibitor fragment (5-24) containing alpha-
hemolysin subunits 
Protein kinase inhibitor fragment (5-24) was inserted approximately at mid-point of Gly/Ser-rich loops to 
generate P115 and P215 constructs, respectively. For P215 construct, fortuitous recombination of 
repetitive Gly/Ser segments were observed for final clone. Therefore, the final constructs were named as 
P115 and P206 for αHL subunits with a PKI fragment-containing loop, which are 115 residues and 206 
residues, respectively. The entire exogenous loop segments were placed upstream of S106 position of 
wild-type αHL. For separation of  the αHL pores with P115 or P206 subunit from the wild-type αHL 
pores, four aspartate residues were attached to C-terminus of the gene. 
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Figure 40. Autoradiographs of the monomeric P115 subunit and heteromeric αHL pore 
with P115 subunit. 
(A) [35S]Methionine-labeled monomeric P115 was resolved in 10% SDS-polyacrylamide gel. P115 
constructs were migrating according to the calculated molecular weights (42 kDa) in 10% gel. As for the 
control, monomeric W subunits were applied in first lane. (B). An autoradiograph of heteromers of P115 
and W subunits formed by IVTT in the presence of rRBCM, under different molar ratio of templates 
(W:P115). The identity of third band of P115/W is unknown and not further studied. (C). To compare the 
electrophoretic migration pattern of the membrane bound oligomers, the homoheptameric wild-type αHL 
pore (first lane) and the heteroheptamers of L115 D4 subunit and W subunit are also shown (third lane). 
Dotted band indicates the oligomers subjected for single channel recordings. As illustrated on the left side 
of the autoradiogram, the first band indicates homoheptameric wild-type αHL pore, and the second band 
for P115/W heteromers with only one P115 subunit and six W subunits, as confirmed by relative intensity 
of each subunits, after re-resolved in 10% gel prior to heating (data not shown). 
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Heteromer Formation 
Radiolabeled monomeric P115 subunit was generated by IVTT in the presence of 
[35S]-methionine. The calculated molecular weight of P115 subunit is 42 kDa, which 
was in good accordance with SDS-PAGE (Figure 40A). Heteromeric P115/W αHLs 
were generated by IVTT in the presence of [35S]methionine and purified rRBCM. There 
were 3 bands in total for the P115/W lane (Figure 40B).The second (heteromer type 1) 
and the third bands (heteromer type 2) were purified subjected for second SDS-PAGE 
analysis after heating. Interestingly both samples gave roughly 1:6 ratio of P115/W 
subunit intensity (data not shown). Furthermore the extent of gel shift for heteromer type 
2 varied from gel to gel (Figure 40C), indicating it might be the P1151W6 heteromer with 
its loop threading out. The P115/W heteromer migration pattern was compared with 
P115/W heteromer (Figure 40C). Charge of the loop (net two positive charges at pH 6.8) 
might contribute for the third band, assuming that same extent of both P115 and L115 
loop were protruding out of the αHL lumen. However this heteromer type 2 was not 
further studied.  
The dotted P115/W heteromer (P1151W6) was purified from preparative 
acrylamide gel and the ability to bind protein kinase catalytic subunit was determined by 
single channel recordings. The purity of P1151W6 heteromer was confirmed by second 
SDS-PAGE (10% acrylamide) after heating the sample (data not shown). P206 construct 
was not investigated further, since the heteromeric pore (P2061W6) generated no changes 
with PKA presence (Figure 41). However, a correlation was observed between the 
length of the inserted loop with the electrical signals, which is similar to Gly/Ser-loop 
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containing αHL pores (see below). 
 
 
 
Figure 41. Traces of P2061W6 heteromeric pore with and without PKA in the chamber. 
The single-channel recording of P2061W6 pores (two channels) in 300 mM KCl, 50 mM MOPS pH 6.8, 1 
mM MgCl2, 100 µM ATP at +80 mV without (A) and with (B) PKA (80 nM, cis) addition. 
 
 
 
Single-molecular Binding Events of PKA to PKI Fragment-containing Loop 
As described earlier, the P2061W6 pore failed to show the PKA binding (Figure 
41), and not assyed further. The single channel recordings of P1151W6 showed PKA 
catalytic subunit binding events at single molecular level, in the presence of 100 µM 
ATP and 1 mM MgCl2. Without the presence of PKA catalytic subunits, the pore 
exhibited high noise electrical signals with an open state amplitude of 14.22 ± 0.01 pA 
(N=5). However, when PKA catalytic subunits were added to the cis chamber (100 nM), 
two types (I and II) of more open states were observed, as shown in Figure 42. The 
dwell time of these events are 3.27 ± 0.67 s (N=27) and 5.16 ± 1.2 s (N=18), with the 
amplitude of 18.45 ± 0.1pA and 17.36 ± 0.01 pA, respectively for the I and II states.  
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Figure 42. Single molecular binding events of PKA to PKI sequence of P1151W6. 
Electrical current flow (A) through the P1151W6  pore was recorded at +80 mV in 5 mM MOPS pH 6.8, 
300 mM NaCl. The signals were acquired at 200 µs intervals and filtered with 3.0kHz Bessel filter. (B) 
Upon addition of the PKA catalytic subunits (100 nM) to cis compartment of the chamber with 1 mM 
MgCl2, 100 µM ATP, two types (I and II) of more open states were observed. A zoomed section of these 
two events was shown in C. 
 
 
 
The dwell time of type I event was in good accordance with that of the αHL 
(T129C-PKI αHL) pore, which is chemically modified by single PKI fragment (5-24) 
polypeptide at the trans mouth. The dwell time of T129C-PKI αHL pore is ~ 3.5 s at –80 
mV, in 300 mM KCl, 15 mM MOPS (pH 6.8) (61). Unlike T129C-PKI αHL pore, upon 
binding of PKA catalytic subunits, the current through the P1151W6 pore was increased 
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6.3%. This is interpleted as the result of loop threading out from the αHL lumen. Similar 
increase of current was observed with L1451W6 and L2151W6 pore, whose loop is 
believed to be out side of the lumen. Other similar characteristics of P1151W6 pore to 
L1451W6 and L2151W6 are, upon binding to the PKA catalytic subunits, the channel 
traces became quiet like the wild-type αHL pore (no substates and the size of the 
amplitude) (Figure 42).  
Since it is known that the binding of MgATP to catalytic subunit changes PKI 
affinity to high affinity, the current through P1151W6 pore was measured with and 
without MgATP in the chamber. Without MgATP, weak binding of PKA to PKI-loop 
was observed (29.8 ± 3.2 µs dwell time with 3.9 Hz frequency), as shown with very 
short binding events (arrowed, Figure 43B,C). With increased concentration of PKA, 
from 50 nM to 100 nM, more frequent short binding events were detected but with 
similar duration (22.1 ± 1.7 µs dwell time with 6.35 Hz frequency). When 100 µM ATP 
and 1 mM MgCl2 were added to cis side of the chamber, more longer binding events 
were detected (3.1 ± 0.1 s) but in scarce frequency (0.5 Hz) This observation account for 
high affinity interaction (dissociation constant Kd = 0.3 nM) of PKA catalytic subunit 
with PKI, when ATP and divalent metal ions were present.  
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Figure 43. The effect of ATP on the interaction of PKA-PKI fragment of P1151W6 pore. 
Electrical current flow (A) through P1151W6 (two channels) was recorded at +80 mV in 5 mM MOPS pH 
6.8, 300 mM NaCl. The signals were acquired at 100 µs intervals and filtered with 3.0 kHz Bessel filter. 
Traces are shown on the left panels and the all-point histograms are shown on the right. To show the 
binding event of PKA (arrowed) from cis side of the pore, 50 nM PKA (B) and 100 nM PKA (C) was 
added to cis chamber. When 100 µM ATP and 1 mM MgCl2 were added to the channel in C, longer 
binding events were observed (D). 
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Summary 
By introducing a heat stable protein kinase fragment (5-24) into αHL pore as a 
part of the exogenous loop (115 residues), the interaction of cAMP-dependent protein 
kinase catalytic subunit and PKI sequences was detected in single molecular level. The 
transient closure of the pore, interpreted as the dynamics of loop near the constriction 
region, was stopped by binding to PKA molecule from outside of αHL lumen. The 
increase of the current amplitude and the dampening of the noise upon binding indicate 
that the loop was stretched out from the cavity. The P1151W6 pore generated different 
kinetic model (Figure 44) with the recently reported T129C-PKI αHL pores (62). For 
the time allowed, this construct was studied in terms of the evidence for the length 
dependent loop encapsulation. 
 
 
Figure 44. Model of PKA capture events of PKI loop-containing αHL pore. 
Capture of PKI fragment by PKA catalytic subunit (I) from the cis side of chamber dampens the electrical 
noise of PKI-containing αHL pore (P1151W6). If the loop is protruding out of the lumen (II), the channel 
shows open state (type II), as the loop becomes stretched and less available in the lumen. However, when 
the loop resides mainly inside the lumen (III and IV), the pores generated fast fluctuation of the current, 
indicating the loop movement near the constriction (IV). 
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The electrophoretic shift and the characteristics of electrical current (the 
amplitude and the current fluctuation) suggested that the loop with ~115 residues are 
protruding out of the αHL lumen. As seen with Gly/Ser loop-containing αHL 
heteroheptamers, the loop length of 145 or 215 residues generated high conductivity 
state without any substates or noise. This characteristic was interpreted as the Gly/Ser 
loop resided mainly outside of the αHL lumen. Similar effect was observed with 
P1151W6 and P2061W6 αHL pores. The electrical current of P1151W6 pores was 
decorated with transient closed states, similar to L1051W6 pore (Figure 28). When the 
PKA catalytic subunits were added to the cis compartment, the signal of this transient 
closure was dampened, indicating capture of inserted PKI fragment sequence by PKA 
catalytic subunits. This result was similar to the interaction of the PEG-tethered αHL 
pore with the streptavidin (7). Interestingly, the amplitude of the current was increased 
when the signal was dampened, indicating the loop is stretched out thus generating less 
occlusion effect of the current flow. Capturing event of the tethered PEG molecule from 
cis side of the lumen, failed to generate the current amplitude changes (7). The volume 
occupied by the hydrated PEG molecue in the αHL central cavity would be smaller than 
the loop of P1151W6, as the reduction of the conductivity was only ~5% with the PEG 
3.4 kDa, whereas it was ~32% with the loop of P1151W6. Therefore, by threading and 
stretching out the loop of make more ionic flow through the αHL pore than with the 
PEG. 
As anticipated, the P2061W6 pore generated unitary high open conductance states 
(Figure 41), simlar to L1451W6 and L2151W6 pore (Figure 28). The pores with these 
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length (≥ 145 residues) of the polypeptide loop are likely to assemble into the heptamers 
with most of the inserted loop already threading out through the cis mouth fo the pore. It 
is supprising to be able to assemble at all, since the amino-latch region, together with 
stem, is where most conformational changes occur during the pre-pore to the pore 
transition. It is not determined that the P1151W6, L1451W6, and L2151W6 pores are in 
the identical conformational state as the wild-type αHL pores. But they formed SDS 
stable oligomer and pores in the lipid bilayer with the similar size of conductance 
(Figure 28, 29, 42). It would be entropically unfavorable to wrap back a protruding loop 
into the confined cavity, as no reversible occurrence of trasient closure was observed for 
all tested pores. On the contrary, the P1151W6 pore exhibited frequent reversible 
occurrence of the transient closed states, even after the loop was stretched out of the 
lumen due to the binding events. It might suggest that it unfavors to be pulled by PKA 
catalytic subunit by producing strain force to αHL mainbody of P115 subunit. More 
detailed study might prove this assumption. 
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CHAPTER VI 
SUMMARY 
 
In the present work, unusual fusion proteins were tested, in which the exogenous 
polypeptide chain (here, loop) was filled into the empty cavity of αHL pore. To evaluate 
the capacity of the central lumen with polypeptide chain, tandem repeat of Gly/Ser linker 
sequence was placed by genetic approaches. With the engineered pores, basal 
information (length dependence L subunit incorporation to oligomers, dynamics of the 
Gly/Ser loop assayed with single channel recordings, and topology of the loop with long 
loop)  were obtained. Amazingly, the αHL was able to form heptamers even with 175 
residues of exogenous sequence.  
Based on these results, temperature-responsive polypeptide (ELP sequence) was 
introduced to the αHL pore. As the ELP undergoes inverse temperature transition, 
E101W6 pores showed the mostly closed states to the mostly open states. By introducing 
different residue for guest residue or different length of the loop, the αHL pores can be 
engineered to gate at different temperatures, or different environmental factors (pH, 
pressure). These results provide fascinating possibilities to develop a simple pore to a 
tool for drug delivery or for delivery of cryoprotectants.  
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Lastly, the possibility to detect analyte from outside of the lumen was 
demonstrated. Designed PKI fragment (5-24)-containing loop was fluctuating in and out 
of the αHL lumen reversibly. Upon addition of the PKA catalytic subunits to the cis 
compartment of the chamber, the interaction with the PKI fragment and the PKA was 
observed. This result demonstrates that the αHL pores could be engineered with 
polypeptide based loops to detect the analytes in and out of the pore. For example, the 
small analytes (20 Å in diameter) could be detected in the lumen, while the large 
analytes (above 20 Å in diameter) will be detected outside of the lumen.  
To extend these projects to the next level, a functional protein (truncated 
photoactive yellow protein (28-125, 98 residues) was engineered into the αHL gene  
with short flanking Gly/Ser linkers (3 residues for N-termini, and 14 residues for C-
termini of PYP) to located in the αHL central cavity. The number of the total exogenous 
residues were 115. The photoactive yellow protein (PYP) is covalently attached to a 
chromophore (p-coumaric acid), which facilitates the study of the chimera protein the 
folding and the function. The maximum absorbance of the chromophore changes from 
335 nm to 450 nm in the light cycle of the native PYP. When the PYP was inserted in 
the αHL gene between postions 105 and 106, the similar absorbance change (from 315 
nm to 432 nm) was observed at the monomeric stage of the chimera protein (PYP-HL), 
suggesting the fusion into the αHL gene was not interfering with the PYP function. This 
result stimulated to generate the heteromers of with the PYP-HL subunit and the W 
subunit. As anticipated, the PYP-HL subunit was incorporated once in the αHL 
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heptamer, as seen with the P1151W6 pore reported in chapter IV. Several different 
approaches were performed to purify the (PYP-HP)1W6 heteromers. However there were 
complications with the purification, since the monomeric chimera protein was 
aggregating constantly. Currently, the improvement for the purificaion conditions is 
investigaing. This unfinished work would generate a possibility to convert a substrate to 
product during the passage through the pore, in future.  
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